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ABSTRACT
PRETERM INFANT GROWTH AND HUMAN MILK EXPOSURE IN THE NICU
by
Lindsay K. Schehr
University of Wisconsin-Milwaukee, 2018
Under the Supervision of Teresa S. Johnson, PhD, RN

Purpose: Examine how feeding practices impact growth in infants less than 1500 grams from
birth until reaching full enteral feedings. Identify growth velocity rates associated with clinician
initiation of fortification of preterm infant human milk feedings.
Design: Retrospective descriptive study
Setting: Level three neonatal intensive care unit in a small urban community in Southeast
Wisconsin.
Participants: A convenience sample of 82 very low birth weight preterm infants who were born
with birth weight < 1500 grams, vaginal or cesarean birth, born at study hospital or transferred to
study hospital within 12 hours of birth.
Methods: Data were collected from the participant’s electronic health records from birth until
the infant reached full enteral feedings.
Results: 82 preterm infants with a mean gestational age 29.30 weeks (SD 3.11) and mean
birthweight 1108.84g (SD 272.77) were included. In those infants that received fortification of
mother’s own milk and/or pasteurized donor human milk (53.7%), mean growth velocity was
3.89 gm/kg/day (SD 12.76) and mean volume of enteral intake was 132.60 mL/kg/day (SD
28.29). When reaching full feeding, mean growth velocity was 0.15 gm/kg/day (SD 11.09).
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Conclusions: Initiation of human milk fortification or lactoengineering earlier in development
may have prevented or decreased extent of growth failure as evidenced by growth velocity less
than 15 gm/kg/day when reaching full enteral feedings.

iii

© Copyright by Lindsay K. Schehr, 2018
All Rights Reserved

iv

DEDICATION
First and foremost, I would like to thank my husband, AJ, standing behind me during every
struggle and each success. Thank you for wearing all hats. You carried me through the last 3
years. You were as important to finishing this degree as I was. You made all the difference in my
success.
To my children, Noah, Zac, and Amelia, thank you for your patience and unconditional love.
You give me energy and strength. You remind me daily of all that is yet to be.
To my mom, Cheryl, you never doubt me, even in times I doubt myself, thank you.
To my family, thank you for your endless encouragement, support, and love along this journey.
To Dr. Teresa Johnson, thank you for serving as my mentor, teacher, and friend for the last 3
years. Our story is unlike any other, from Amelia to world travels, thank you for your guidance
and support. You have inspired me to imagine a world where it is possible for all children to
access optimal nutrition: human milk. Your encouragement and enthusiasm has inspired to use
nursing research and practice to make this achievement a reality.
To my dissertation committee, Drs. Michele Polfuss, Kris Barnekow, and Sandeep
Gopalakrishnan, thank you for your valuable insight and most precious gift of time.
I am exiting this doctoral program with many friendships, an expanded mind, a full heart, and
greater sense of what I am capable of. “She believed she could, so she did.”

v

TABLE OF CONTENTS
Abstract .......................................................................................................................................... ii
List of Figures ............................................................................................................................... ix
List of Tables ..................................................................................................................................x
Chapter I: Introduction ....................................................................................................................1
Background .........................................................................................................................1
Problem Statement ..............................................................................................................3
Target Population and Rationale .........................................................................................3
Purpose of the Study ...........................................................................................................4
Primary Research Aim ........................................................................................................4
Research Questions .............................................................................................................4
Primary Research Questions ...................................................................................4
Secondary Research Questions ...............................................................................5
Conceptual Framework .......................................................................................................5
Significance .........................................................................................................................7
Assumptions ........................................................................................................................8
Structure of Dissertation .....................................................................................................8
Chapter II: Conceptual Analysis .....................................................................................................9
Chapter III: Review of the Literature ............................................................................................18
Appropriate Preterm Infant Growth ..................................................................................18
Consequences of Growth Failure ..........................................................................20
Consequences of Catch-Up Growth ......................................................................21
Current Measures of Growth ............................................................................................23

vi

Anthropometric Measures .....................................................................................23
Growth Charts .......................................................................................................26
Body Composition ............................................................................................................28
Compartment Methods ..........................................................................................28
Gold Standard Methods ........................................................................................29
Reference Methods ...............................................................................................30
Predictive Measures ..............................................................................................33
Preterm versus Term Infant Body Composition ...................................................35
Delivery of Nutrition in the NICU ....................................................................................35
Parental Nutrition ..................................................................................................36
Enteral Nutrition ...................................................................................................37
Oral Feeding ..........................................................................................................39
Demand Feedings ..................................................................................................40
Types of Nutrition .............................................................................................................40
Human Milk ..........................................................................................................41
Formula .................................................................................................................44
Fortification of Human Milk .............................................................................................45
Types of Fortifier ..................................................................................................47
Fortification Methods ............................................................................................48
Lactoengineering ...................................................................................................50
Cost of Human Milk Use in the NICU .............................................................................50
Current Recommendations for Preterm Infant Feeding and Growth ................................52
Gaps in Knowledge ...........................................................................................................52

vii

Summary ...........................................................................................................................53
Chapter IV: Methodology .............................................................................................................55
Research Design ................................................................................................................55
Sample ...................................................................................................................55
Procedure ..............................................................................................................56
Protection of Human Subjects ..............................................................................56
Measurements/Variables .......................................................................................56
Data Management Plan .........................................................................................62
Analysis .............................................................................................................................63
Chapter V: Study Results ..............................................................................................................65
Chapter VI: Implications for Nursing Practice, Research, and Policy .........................................89
Implications for Nursing Practice .....................................................................................89
Implications for Further Research ....................................................................................91
Comprehensive References .........................................................................................................105
Curriculum Vita ..........................................................................................................................128

viii

LIST OF FIGURES
Figure 1. Physiological Preterm Infant Growth Model ..................................................................6
Figure 2. Different models of body composition used for infants ................................................29
Figure 3. Stratification of type of nutritional intake .....................................................................57
Figure 4. Growth velocity by percent of human milk intake ........................................................59

ix

LIST OF TABLES
Table 1. Composition of Major Components of Human Milk .....................................................42
Table 2. Measure and Data Management Chart ............................................................................61

x

Chapter 1: Introduction
Background
Most health care providers guided by the American Academy of Pediatrics (AAP) strive
to prescribe nutritional practices in the neonatal intensive care unit (NICU) to achieve growth
comparable to intrauterine life (Hay, 2013; Kleinman & AAP, 2009; Puntis, 2006). The
recommended standard intrauterine growth rate is 15 gm/kg/day (Kleinman & AAP, 2009).
Intrauterine growth is accepted as the standard for preterm extrauterine growth because a
superior growth standard remains undefined (Fenton & Kim, 2013).
After a preterm infant regains initial weight loss from birth, weight gain at the
recommended growth velocity of 15 gm/kg/day can still result in growth failure (Martin et al.,
2009; Reali et al., 2015; Ruth, 2008). Martin et al. (2009) categorized growth failure as weight
less than the 10th percentile for postmenstrual age on a standardized intrauterine growth chart.
Martin et al. (2009) reported that when the study infants exceeded the growth velocity of 15
gm/kg/day, growth failure still occurred in 75% of the 1,187 infants studied.
Nutrition management to produce adequate growth of preterm infants remains one of the
most challenging aspects of care. The types, amounts, and frequencies of feedings during the
initial hospitalization have important implications for future infant growth and development of
preterm infants. The estimated nutritional requirements for preterm infants are driven by nutrient
accretion and growth of a third trimester fetus in attempt to mirror the intrauterine growth
standard (Tudehope, 2013). The resulting recommendations for nutritional requirements,
including macronutrient and micronutrient intake, are based primarily on expert opinion to reach
a growth standard that may not be optimal (Tudehope, 2013). This leads to continued
controversy among health care providers regarding optimal prescribed feedings.
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Human milk is regarded as the superior and preferred feeding method for hospitalized
preterm infants (Menon & Williams, 2013). However, significant controversy continues how
human milk should be provided or fortified or lactoengineered to support optimal growth
(Menon & Williams, 2013). For infants whose mothers cannot provide breastmilk, infants may
be fed pasteurized donor human milk (PDHM), which they should receive, at minimum, until 34
weeks corrected gestational age or 28 days of life (Parker, Barrero-Castillero et al., 2013).
Despite the known benefits of exclusive human milk feedings, many health care providers caring
for preterm infants supplement human milk with bovine milk-based fortifier and/or formula to
provide additional protein, calories, and other nutrients to try to maximize growth acceleration
(Menon & Williams, 2013).
Growth failure among preterm infants has consequences for short- and long-term health.
Preterm infant growth failure is associated with adverse neurodevelopmental outcomes and
somatic development, longer NICU stay, and potentially preventable morbidities (McLeod &
Sherriff, 2007; Vasu & Modi, 2007; Walker, Keene, & Patel, 2014). Growth failure can
contribute to impeded brain growth resulting in irreversible neurodevelopmental deficits,
including abnormal motor and cognitive function (Butler, Szekely, & Grow, 2013; McLeod &
Sherriff, 2007; Walker et al., 2014). Growth failure in preterm infants and subsequent infant
catch-up growth is related to increased risk for disease in adulthood, including decreased insulin
sensitivity, increased insulin resistance, altered adipose tissue metabolism (Finken et al., 2006 ),
obesity, and hypertension (Thomas et al., 2011). The risks associated with growth failure or
contrary rapid catch-up growth has potential health implications that must be weighed heavily
when evaluating goal growth standards among preterm infants.
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As preterm infants are not a homogenous group, a major conceptual flaw is created when
using a standard growth rate to define optimal growth (Embleton, Cleminson, & Zalewski,
2017). Preterm infant growth is multifactorial based on maternal, fetal, and infant physiological,
developmental, genetic, nutritional, and environmental factors that differ in each preterm infant.
As these variables differ among preterm infants, it is apparent that an intrauterine rate of growth
for one infant may be sufficient, but a slower trajectory may be more appropriate and
biologically plausible for the next infant (Embleton et al., 2017).
Problem Statement
It is unclear what combination of neonatal nutrition is most highly associated with
optimal preterm infant health, growth, and development (Rice & Valentine, 2015).
Supplementation of human milk is often quickly and frequently performed in NICUs with bovine
fortification and/or formula to reach a growth standard that may not be appropriate (Menon &
Williams, 2013). Nutritional management of preterm infants is marked by a lack of practice
uniformity (Wight et al., 2008). Heterogeneity of nutrition practices can be seen in every aspect
of nutritional management from the first hour of life to NICU discharge (Wight et al., 2008).
There is lack of evidence to demonstrate that it is optimal or safe to set the goal of extrauterine
growth of preterm infants to mimic intrauterine growth (Pereira-da-Silva & Virella, 2014).
Comprehensive and multidisciplinary nutritional monitoring associated with growth outcomes is
not consistent in NICUs (Wight et al., 2008).
Target Population and Rationale
The target population is preterm infants born less than 37 completed weeks gestation and
weighing less than 1,500 grams. A preterm infant is defined as born at less than 37 completed
weeks gestation (Mosby, 2006). The target population is considered very low birth weight
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(VLBW). Very low birth weight infants are defined as infants born at less than 1,500 grams
(Wight et al., 2008). Survival rates of VLBW infants have improved; therefore, more attention
needs to be focused on the quality of survival through optimal nutrition management (McLeod &
Sherriff, 2007; Thoyre, 2007).
Purpose of the Study
The purpose of the this study is to examine how feeding practices impact growth in
infants less than 1500 grams from birth until reaching full enteral feedings.
Primary Research Aims
1. Understand how the type and amounts of feedings are associated with preterm infant
growth during the initial birth hospitalization.
2. Identify growth velocity rates associated with clinician initiation of fortification of
preterm infant human milk feedings.
Research Questions
Primary Research Questions
1. What is the growth velocity (gm/kg/day) of VLBW preterm infants at the time human
milk fortification is initiated?
2. Is there a relationship between growth velocity (gm/kg/day) of VLBW preterm
infants from birth to full feeding and percentage of human milk intake?
3. Is there a relationship between growth velocity (gm/kg/day) of VLBW preterm
infants from birth to full feeding and percentage of mother’s own milk, pasteurized
donor milk, and mixed donor/mother’s own milk intake?
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Secondary Research Questions
1. What is the volume of enteral intake (mL/kg/day) at the time human milk fortification
is initiated?
2. What is the average day of life when birth weight is regained?
3. When full feedings are achieved, on average, how many kilograms is the infant from
birth weight?
4. What is the average day of life that enteral feedings are initiated?
5. What percentage of infants experience suboptimal growth, as measured by a growth
velocity < 15 gm/kg/day, when reaching full feedings in the NICU?
Conceptual Framework
A comprehensive conceptual model or theory appropriate to guide research of preterm
infant growth failure in the NICU was not identified in the literature. As foundational work, this
writer has created a physiological preterm infant growth model based on frequently associated
concepts and variables (see Figure 1). Scientists and clinicians attempt to understand these
conceptual relationships by building research and practice from a theoretical perspective.
Conceptualization and theory are needed to systematically expand nursing discipline’s
knowledge (Meleis, 2007). By examining the phenomena of preterm infant growth and nutrition
from a theoretical lens, we can categorize what is known of phenomena, indicate gaps in nursing
knowledge, and point out where further knowledge should be developed. The frequently
associated physiological concepts seen repeatedly in the literature to define and describe preterm
infant growth and nutrition were used to create the Physiological Preterm Infant Growth Model.
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Figure 1. Physiological Preterm Infant Growth Model.
The Preterm Infant Physiological Growth Model is considered a practice-based
framework. Meleis (2012) argues that practice-based frameworks are appropriate when theories
do not exist or are not useful to describe the phenomena or population. When current theoretical
material does not translate into practice or is not relevant to the phenomena, it may be
appropriate to inductively develop the framework (Meleis, 2012). This model provides clear,
identifiable and measurable variables to define optimal growth and to explain the physiologic
complexity of factors that can interfere with optimum preterm infant growth.
There are multiple systems that impact a preterm infant’s intrauterine and extrauterine
growth. There is a dynamic interaction between maternal, fetal, and infant physiological,
developmental, genetic, nutritional, and environmental factors that influences preterm infant
growth. As the biological foundations and risk factors identified in the Physiological Preterm
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Infant Growth Model vary, it is apparent that an intrauterine rate of growth may not be
biologically plausible for all preterm infants (Embleton et al., 2017). The Preterm Physiological
Growth Model provides a foundation to explain that preterm infants are not homogenous in their
risk for growth outcomes and demonstrates that the current growth standard is conceptually
flawed. The Physiological Preterm Infant Growth Model provides foundational concepts to
inform the association of nutritional support and infant growth in this dissertation. The concepts,
as explained in the Physiological Preterm Infant Growth model, have influenced understanding
of salient components of preterm infant growth as a phenomenon. This model guided
investigation to solidify the definition of growth failure in hospitalized preterm infants through
concept analysis further discussed in Chapter 2. The Physiological Preterm Infant Growth Model
will require continued development in the future.
Significance
Preterm infant birth is the second leading cause of mortality worldwide (Partnership for
Maternal, Newborn, and Child Health, 2011). In 2015, approximately 3,977,745 births were
reported in the United States (Hamilton, Martin, & Osterman, 2016). Of these births, 55,290
(1.39%) were considered VLBW (Hamilton et al., 2016). Very low birth weight preterm infants
who survive commonly experience growth deficiency (Steward, 2012). Approximately 90% of
VLBW infants are considered growth restricted, falling below the 10th percentile on a
standardized intrauterine growth curve, by 36 weeks gestational age (Dusick, Poindexter,
Ehrenkranz, & Lemons, 2003).
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Assumptions
Assumptions for this study were that the types of preterm infant nutritional practices are a
determinant of growth. Further, it was assumed that the type of nutritional practice would predict
the relationship between study variables.
Structure of Dissertation
This dissertation is comprised of six chapters, within which are three manuscripts
accepted and/or readied for publication. Chapter II presents manuscript one, “A Concept
Analysis of Growth Failure in Preterm Infants in the NICU,” used to examine the fundamental
elements and to provide an operational definition of the concept of growth failure in preterm
infants in the NICU. Chapter III provides a review of literature on preterm infant growth and
nutrition. Chapter IV presents the research methodologies and study design. Chapter V presents
manuscript two, “Preterm Infant Growth and Human Milk Exposure in the NICU,” used to
present and discuss study results. Finally, Chapter VI discusses implications to nursing research,
practice, and policy; and presents manuscript three, “The Political Imperative of an Exclusive
Human Milk Diet.”
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Chapter II: Conceptual Analysis
After construction of the Physiological Preterm Infant Growth Model, the next
conceptual step in this dissertation was to examine the specific concept and definition of preterm
infant growth. The current state of the science on preterm infant growth did not provide
researchers or clinicians with sufficient literature to determine optimal growth for preterm infants
(Embleton et al., 2017). The literature review revealed it is apparent that the same rate of growth
is not biologically plausible for all preterm infants (Embleton et al., 2017). Considering there is
lack of consensus on what appropriate growth is, it was then a reasonable step to conceptualize
what growth is not.
Conceptualization is critical to defining, describing, clarifying, explaining, and
understanding phenomena (Meleis, 2007). Ultimately, conceptual analysis provides a sound
organization of concepts, clarifies vague phenomena, and provides a symbolic representation of
reality to support the concept’s theoretical basis (Walker & Avant, 2011). Through conceptual
analysis, an operational definition of growth failure in preterm infants in the NICU was
constructed.
In the following section of Chapter II is a manuscript published in the Journal of
Obstetric Gynecologic and Neonatal Nursing: “A Concept Analysis of Growth Failure in
Preterm Infants in the NICU.” This publication was available online October 2017 and in print
November/December 2017. “A Concept Analysis of Growth Failure in Preterm Infants in the
NICU” was created utilizing Walker and Avant’s (2011) steps to concept analysis as
foundational work for this dissertation.
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Chapter III: Review of the Literature
Many questions remain unanswered or unclear surrounding preterm infant growth and
nutrition, including: What is appropriate growth? How should growth be measured? Are our
current measurement tools of growth reliable? Should preterm nutrition be fortified or
lactoengineered? What are the optimal nutritional practices to produce optimal growth? How
should nutrition be delivered? The purpose of this chapter is to review the literature on preterm
infant growth and nutrition management to examine the current state of the science and to
identify the gap in literature for questions such as these. This review of literature is organized by
seven sections: appropriate preterm infant growth, current measures of growth, body
composition, delivery of nutrition in the NICU, types of nutrition, fortification of human milk,
and cost of human milk in the NICU. By examining the current literature, the gaps in knowledge
related to preterm infant nutrition and growth can be discovered and recommendations for future
research can be made.
Appropriate Preterm Infant Growth
In this section, I will review the importance of appropriate preterm infant growth and the
subsequent consequences that occur when preterm infants experience growth failure and/or
catch-up growth.
Most health care providers guided by the AAP strive to prescribe nutritional practices in
the NICU to achieve growth and body composition comparable to intrauterine life (Hay, 2013;
Kleinman & American Academy of Pediatrics, 2009; Puntis, 2006). Intrauterine growth is
commonly used as the standard for extrauterine growth of preterm infants because a superior
growth standard remains undefined (Fenton & Kim, 2013). The recommended growth standard
based on intrauterine growth is 15 gm/kg/day (Poindexter, 2014). If this growth standard was an
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appropriate goal, the challenge still exists that there are not existent guidelines on how to achieve
this fetal growth rate, as the actual nutrients delivered in utero are unknown (Sauer, 2007).
However, there is lack of evidence to demonstrate that it is optimal or safe to set the goal of
extrauterine growth of preterm infants to mimic intrauterine growth (Pereira-da-Silva & Virella,
2014). The recommended growth standard is controversial, because the reference fetus used to
develop this standard was based on a small data set and was not gender specific. Intrauterine
growth commonly reflects an ideal growth pattern that is rarely achieved in hospitalized preterm
infants (Horemuzova, Söder, & Hagenäs, 2012). Based on applying intrauterine growth
standards, hospitalized preterm infants frequently experience growth failure (Martin et al., 2009).
Preterm infant growth failure is frequently defined as weight less than the 10th percentile
for postmenstrual age on a standardized growth chart at discharge from the NICU (Martin et al.,
2009; McLeod & Sherriff, 2007; Ruth, 2008). Approximately 90% of very low birth weight
(VLBW) infants are classified as having experienced growth failure by 36 weeks corrected
gestational age (Dusick et al., 2003). Growth failure in preterm infants is associated with growth
velocity rates less than 15 gm/kg/day in weight, 0.5 to 0.7 cm/week in head circumference,
and/or 1 cm/week in length (Greer & Olsen, 2013; Griffin, 2017). Growth velocity is calculated
as increase in grams per kilogram per day (Greer & Olsen, 2013; Patel, Engstrom, Meier, Jegier,
& Kimura, 2009) and increase in centimeters per week in head circumference and length (Greer
& Olsen, 2013).
Weight gain at the recommended growth velocity of 15 gm/kg/day can still result in
failure to return to birth weight percentile when plotted on a standard preterm infant growth chart
(Martin et al., 2009; Reali et al., 2015; Ruth, 2008). Martin et al. (2009) reported that even when
the study infants exceeded the growth velocity of 15 gm/kg/day, growth failure occurred in 75%
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of the 1,187 infants studied. Reali et al. (2015) reported that despite an average growth velocity
of 16.04 gm/kg/day in preterm infants during their hospitalizations, 72.3% weighed less than the
10th percentile on a standard preterm infant growth chart at discharge from the hospital.
There are multiple reasons for postnatal preterm infant growth failure. While we
commonly consider nutrition as the cause of growth failure in preterm infants, conditions
including genetic-acquired diseases, liver disease, endocrine abnormalities, surgery, infections,
sepsis, ventilator dependence, respiratory distress, persistent pulmonary dysfunction,
hypothermia, cold stress, and postnatal exposure to dexamethasone are also contributing factors
(Bartholomew et al., 2013; Hay, Brown & Denne, 2014; Vinall et al., 2012). The drugs used to
treat biological conditions prenatal in mother and fetus and postnatal in the infant can also
negatively affect infant nutrient metabolism and growth (Hay, 2013).
Consequences of Growth Failure
Preterm infant growth failure is associated with adverse neurodevelopmental outcomes,
decreased somatic development, longer NICU stay, and potentially preventable morbidities
(McLeod & Sherriff, 2007; Vasu & Modi, 2007; Walker et al., 2014). In humans, brain growth is
most rapid in the time immediately before and after birth (Embleton & Tinnion, 2009). In the
time between 24 weeks gestation and two years after birth, the brain reaches 90% of its final
volume (Embleton & Tinnion, 2009). Malnutrition and subsequent growth failure in preterm
infants that occurs during this postnatal period can impact both the function and structure of the
brain and development of the retina (Uauy & Mena, 2001). Impeded brain growth can result in
irreversible neurodevelopmental deficits, including abnormal motor and cognitive function
(Butler et al., 2013; Embleton & Tinnion, 2009; McLeod & Sherriff, 2007; Walker et al., 2014).
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Consequences of Catch-Up Growth
Catch-up growth is defined as length and weight gain greater than intrauterine growth
rate for gestational age during a preterm infant’s first weeks of life (Roggero et al., 2009; Sauer,
2007). There appear to be benefits and consequences of catch-up growth. While some
researchers suggest that catch-up growth is required for preterm infant brain development, others
report that it places the infant at increased risk of harmful cardiovascular and metabolic
outcomes later in life (Kiger, Taylor, Wagner, Finch, & Katikaneni, 2016; McLeod et al., 2015;
Ong, Ahmed , Emmett, Preece, & Dunger, 2000; Sauer, 2007).
The concern of rapid catch-up growth is based on the concept of Barker’s hypothesis,
which demonstrates a relationship between fetal and neonatal growth, and alteration of
subsequent metabolic and cardiac function (Hales & Barker, 1992). Hales & Barker (1992)
hypothesized that low birth weight infants undergo fetal programming, which causes
physiological adaptations in response to the intrauterine environment to increase likelihood of
postnatal survival. It is not clear whether the growth and fat deposition itself is harmful or
whether the growth is related to nutritional adaptations and metabolic programming that increase
risk for later disease (Wells, 2012).
Preterm infants commonly display intra-abdominal adiposity and abnormal body
composition during catch-up growth (Strydom, Van Niekerk & Dhansay, 2017). Rapid accretion
of adipose tissue may cause adverse neonatal programming that can include changes in organ
structure and function, including muscle mass, beta cell mass, and nephron number, which
contributes to metabolic capacity (Wells, 2012). Muhlhausler et al. (2009) reported that rapid
catch-up growth was associated with upregulation of IGF1 receptors and insulin, which is
mediated by nutritional intake that can contribute to later metabolic risk. Deposition of visceral
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intra-abdominal fat in preterm infants may increase risk for disease in adulthood, including
increased insulin resistance, decreased insulin sensitivity, type II diabetes, altered adipose tissue
metabolism, metabolic syndrome, cerebrovascular accident, cardiovascular disease, and obesity
(Barker, 1997; Barker, Eriksson, Forsen, & Osmond 2002; Embleton et al., 2017; Finken et al.,
2006; Strydom et al., 2017; Thomas et al., 2011; Yeung, 2006). Metabolic capacity is strongly
correlated with chronic disease risk (Wells, 2012). These changes to organ structure and function
are strongly dependent on fetal and early infant growth (Wells, 2012).
Rapid catch-up growth appears to pose most risk during the first few weeks of life
(Stettler et al., 2005). Some researchers suggest that high birth weight may index metabolic
programming over the lifespan (Barker, 1997, Wells, 2012). In contrast, other researchers argue
that it is the change in size of the infant and not birth weight, which is the primary factor that
contributes to increased metabolic and cardiac disease risk (Singhal & Lucas, 2004). In a
longitudinal study, rapid body mass index (BMI) gain in preterm infants at calendar age four, 12,
and 18 months was associated with higher odds of being overweight or obese at eight and 18
years of age (Belfort, Gillman, Buka, Casey, & McCormick, 2013).
There is not a clear understanding by researchers and clinicians of the consequences of
too rapid growth. The current literature on preterm infant catch-up growth and subsequent
increased body fat suggests that the current growth and nutrition recommendations are not
effective or safe to achieve normalized body composition postnatally. Breastfeeding has been
shown to promote slower growth, while artificial feeding may stimulate higher growth velocity
postnatally (Oddy, 2012). Human milk can induce lower plasma insulin levels resulting in
decreased fat storage, preventing excessive development of adipocytes resulting in a protective
effect on obesity (Oddy, 2012). It is possible that lower nutrient intake and slower growth may
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be protective longitudinally for preterm infants (Embleton et al., 2017). Future research is needed
to examine the relationship between fetal and neonatal growth and alteration of subsequent
metabolic and cardiac function to prevent risk for harm later in life.
Current Measures of Growth
In this section, I review the current measures of growth most frequently utilized in the
NICU. I will begin by examining how the literature defines and describes growth. Second, I will
describe anthropometric measures and growth charts, including the reliability and utility of these
measures. Accurately obtained anthropometric measures serve as the current best practice in the
NICU to measure growth and manage growth issues (Greer & Olsen, 2013).
Growth is described as an increase in size of tissue because of increase in intracellular
substance or multiplication of cells (Shrestha, 2017). Preterm infant growth requires constant
evaluation as it is used to inform daily nutritional practices in the NICU (Greer & Olsen, 2013).
Both quantitative and quality measures of preterm infant growth are important to identify and
describe target growth rates. Quantitative measures include anthropometric and body
composition measures. Quality measures include body composition measures.
Anthropometric Measures
The most common anthropometric measurements obtained on preterm infants in the
NICU include weight, length, and head circumference (Anderson, 2014). The frequency of these
measures should include accurate weights obtained daily and length and head circumference
measurements obtained weekly (Anderson, 2014; Greer & Olsen, 2013; Poindexter, 2014).
These measures should be plotted on a standardized growth chart at the same time each week
during the NICU stay (Anderson, 2014, Greer & Olsen, 2013; McLeod & Sherriff, 2007). The
data obtained from the anthropometric measures should then be used to calculate growth velocity
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(Greer & Olsen, 2013). Growth velocity is calculated in gm/kg/day and cm/week (Greer &
Olsen, 2013).
The reliability of these anthropometric growth measures has been questioned. It is
important to determine the reliability of obtaining anthropometric measures, as inaccurate
neonatal measurements can contribute to inappropriate nutritional management and failure to
detect growth failure (Wood, Raynes-Greenow, Carberry, & Jeffery, 2013). Emphasis is
commonly placed on accurate weight measures when evaluating nutritional practices, which can
result in viewing length and head circumference as secondary measures. As a result, the
importance of reliability and accuracy of length and head circumference are often overlooked in
clinical practice (Wood et al., 2013). In examination of preterm infant growth studies, it is vital
to comprehend the reliability of these anthropometric measures, as they are a direct indicator of
the quality of data.
While head circumference measures are an important reflection of brain growth, the
precision and accuracy in obtaining correct measures is lacking (Embleton et al., 2017). Bhushan
and Paneth (1991) reported 5% of the head circumference measures in 1,105 infants weighing
less than 2,000 grams differed by 2 cm or greater. Sutter, Engstrom, Johnson, Kavanaugh, and
Ifft (1997) reported that head circumference measures of preterm infants using a paper tape was
more reliable than use of cloth tape measures.
Multiple techniques are available to measure infant lengths. Length-board measures
obtained by trained professionals have been reported as being the most reliable (Johnson,
Engstrom, Warda, Kabat, & Peters, 1998; Corkins, Lewis, Cruse, Gupta, & Fitzgerald, 2002).
Corkins et al. (2002) reported an average difference of 2.23 cm between tape measure measures
and length board measures; while this was not statistically significant, it was clinically
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significant. The difference in these measures resulted in 13 of 25 patients having a change in
weight for length percentile (Corkins et al., 2002). Johnson et al. (1998) reported that crown-heel
technique was the least reliable length measurement method in full term infants. Length board is
accepted as the standard for obtaining length measures with reproducible accuracy within 0.2 cm
to 0.4 cm (Feucht, 2000).
The reliability of weight measurements is influenced by multiple factors, including
method of reading and recording weights, number of individuals performing the measures,
balance of scale, technique, constancy of infant conditions, and type of scale (Kavanaugh, Meier,
& Engstrom, 1989). Kavanaugh, Engstrom, Meier, and Lysakowski (1990) reported that type of
scale may be the most crucial control for reliability. Kavanaugh et al. (1990) examined weight in
50 preterm infants and reported that an electronic scale was more reliable than the mechanical
scale. The mean difference for intrarater measures was 5.5 grams (mechanical scale) and 1.36
grams (electronic scale, Kavanaugh et al., 1990). The percent of interrater difference more than 5
grams was 0% for electronic scale and 66% for mechanical scale (Kavanaugh et al., 1990).
Kavanaugh et al. (1989) reported that mechanical scales do not have the sufficient reliability for
use in research.
While the current available literature discussed reviewing reliability of weight, length,
and head circumference techniques are dated, they serve as landmark studies. The measurement
devices have not made significant technological advances since the time these research studies
were published. The gap in literature examining the reliability of anthropometric measures
within the preterm infant population exists because there are very few growth studies that
provide detailed measurement reliability assessments and description of anthropometric
standardization (Onis, 2006).
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Other anthropometric indices, including ponderal index (weight/length^3), body mass
index (BMI or weight/length^2), body surface area, Benn index, and weight to length ratio, may
be useful to examine body proportionality as a proxy for body composition (Greer & Olson,
2013; Kiger et al., 2016). However, these methods have not been validated to estimate preterm
infant body composition (Kiger et al., 2016). Kiger et al. (2016) reported that when
anthropometric measures were examined that BMI most closely predicted percentage body fat.
Body mass index only had a low predictive value for body fat, with a predictive power of 51% in
infants less than 50 weeks post menstrual age and 16% in infants greater or equal to 50 weeks
post menstrual age. Further research is needed to validate these anthropometric indices to
examine body proportionality as a proxy for body composition in preterm infants.
Growth Charts
Clinicians use growth charts in the NICU to document a visual display of growth over
time. Growth measures plotted on growth charts are utilized to make daily informed
recommendations on preterm infant feeding (Greer & Olsen, 2013). Although multiple growth
charts have been developed to monitor infant growth, the two primary types of growth charts in
the NICU are growth standard charts and growth reference charts. The selection of growth charts
used in NICUs depends on local practice and provider preference (Griffin, 2017).
Growth reference charts are descriptive and represent how a population is growing (Villar
et al., 2010). Growth reference charts are created based on statistical summary of anthropometric
measurements of a reference group (Villar et al., 2010). Growth reference charts include fetal
estimation curves, birth weight for gestational age charts, and postnatal longitudinal growth
charts (Villar et al., 2010). Fetal estimation curves are based on fetal ultrasound anthropometric
measurements across multiple gestational ages. Birth weight for gestational age charts represent
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actual growth of infants constructed from a single anthropometric measure of weight obtained at
birth across multiple different gestational ages. Postnatal longitudinal growth charts represent
actual postnatal growth from a reference group over time. Growth reference charts describe
anthropometry of the population, but they do not account for environmental, nutritional,
socioeconomic, and health conditions (Bertino, Milani, Fabris, & De Curtis, 2007).
In contrast, growth standard charts define how a population should be growing under
optimal nutritional and environmental conditions, as opposed to how they have grown during a
specific time and place (Giuliani et al., 2016; Villar et al., 2010). Growth standard charts
represent longitudinal monitoring of prospective healthy growth (Villar et al., 2010). However,
growth standard charts do not inform preterm infant growth assessments until infants reach
postmenstrual age equal or greater to 37 weeks (Fenton & Kim, 2013). Postmenstrual age is
defined as gestational age plus chronological age post-birth (Engle, 2004).
The 2013 Fenton Preterm Growth Chart, a growth reference chart, is one of the most
widely used growth charts to monitor preterm infant growth in the NICU (Fenton & Kim, 2013).
This growth chart combines fetal growth patterns based on weight for gestational age for preterm
infants combined with the World Health Organization (WHO) growth standards of term infants
(Fenton & Kim, 2013). The strength of the 2013 Fenton Preterm Growth Chart is that it provides
a single tool that assesses how the infant grew while in the uterus based on birth weight and then
is used to monitor postnatal growth to and beyond term (Pereira-da-Silva & Virella, 2014).
Major revisions of preterm infant growth charts have been made over the past 5 to 10
years in efforts to recognize the importance of nutrition and growth and in an attempt to quantify
preterm infant growth (Kiger et al., 2016). The growth charts available serve well to statistically
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describe anthropometric measures of growth; however, there is no causal relationship between
these measures and estimation of actual body composition (Kiger et al., 2016).
Body Composition
In this following section, I review how quality of growth is measured quantitatively by
measuring body composition. There are multiple methods currently available to assess preterm
infant body composition. The methods used to examine preterm infant body composition will be
described as compartment models (see Figure 2). Furthermore, the different compartment models
fit into three broadly categorized methods and are described as: gold standard methods, reference
methods, and predictive methods. Lastly, I examine the differences and similarities between
preterm infant and term infant body composition.
Weight is described as the sum of the mass (Johnson, 2003). Some researchers have
argued that weight gain by itself is not adequate to inform the practice of nutrition on growth
(Forsum, Olhager, & Tornqvist, 2016). It has been suggested that instead, body composition
should be measured as a parameter of growth to inform nutritional practices (Forsum et al.,
2016). This is a paradigm shift from focusing on the quantity of growth to the quality of growth
in preterm infants. Body composition of preterm infants is widely variable (Kiger et al., 2016).
Understanding the composition of growth is vital, as it may be predictive of future disease risk
(Wells, 2012).
Compartment Methods
The methods discussed within this paper used to measure preterm infant body
composition include two-, three-, and four-compartment models. These methods examine body
composition by dividing body weight into compartments that contain distinctive components
(Ellis, 2007; Strydom et al., 2017). Each compartment method is built upon the previous method.
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The earliest and most frequently used model is a two-compartment model (Ellis, 2000). The twocompartment model examines body composition in two components: fat free mass (FFM) and fat
mass (FM; Ellis, 2000; Wells, 2012). Fat free mass includes internal organs, muscle, bone, water,
and connective tissue. Fat mass includes adipose tissue and fat (Strydom et al., 2017). The threecomponent model measures FM and divides FFM into two parts: water and any remaining solids
(Ellis, 2000). A limitation of the three-compartment model is that if the body protein and/or bone
mineral mass is depleted, the density of solids is inaccurate (Ellis, 2000). Thus, the fourcompartment model was created and measures FM and divides FFM into three physiological
compartments: body cell mass, extracellular water, and extracellular solids (Ellis, 2000).
Fat mass (FM)

Fat mass (FM)

Fat mass (FM)

(Adipose tissue and fat)

(Adipose tissue and fat)

(Adipose tissue and fat)

Fat-free mass (FFM)

Water

Body Cell Mass
(BCM)

(Carbohydrates, protein,
water, and minerals)
Fat-free mass (FFM)
(Carbohydrates, protein,
and minerals)

Extracellular water
(ESW)

Extracellular Solid
(ECS)
Two-compartment

Three-compartment

Four-compartment

Figure 2. Different models of body composition used for infants (adapted from Ellis, 2007, and
Strydom et al., 2017).
Gold Standard Methods
Magnetic resonance imaging (MRI). Magnetic resonance imaging uses strong magnetic
field to align water molecules that contain hydrogen nuclei (Ellis, 2000). The intensity of the
signal can measure the number of hydrogen nuclei in the body tissue (Ellis, 2000). This process
provides detailed visual cross-sectional images of the body and can measures total body fat,
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abdominal fat, visceral fat, subcutaneous fat, and ectopic fat (Ellis, 2000; Wells, 2012). There are
limitations in use of MRI for preterm infant body composition assessment. Magnetic resonance
imaging scanning is costly, requires special facilities and specialized computer software for
infants, requires removal of the infant from the NICU, and necessitates the infant to be still for
accurate results (Wells, 2012). There is also a high demand of MRI for clinical diagnostic use,
which limits availability for use of body composition assessment (Ellis, 2007).
Reference Methods
Dual-energy x-ray absorptiometry (DXA). Dual-energy X-ray absorptiometry utilizes,
Low intensity collimated X-ray beams at two energies to scan the whole body or at specific bone
sites, such as the hip and spine…. For a whole body scan, values for body fat and non-fat soft
tissue mass are obtained. (Ellis, 2007, p. 89).
There are limitations of use of DXA in preterm infants. Dual-energy x-ray
absorptiometry is expensive, requires the infant to be removed from the NICU, and requires the
infant to be still for accurate results (Ellis, 2007). There are also concerns over low level
radiation that is used in DXA during the sensitive developmental window in preterm infants
(Wells, 2012).
Isotope dilution. Isotope dilution utilizes a tracer administered orally or intravenously,
and the volume of a compartment can be defined as the ratio of the dose of this tracer to its
concentration in that body compartment (Ellis, 2000). Generally, a fluid sample of blood, urine,
or saliva is obtained prior to administration of the isotope tracer for baseline and then a second
sample is obtained after waiting the appropriate amount of time for the tracer to penetrate the
compartment of interest (Ellis, 2000). Isotope dilution has been successful after six weeks of
birth in providing data on FFM and FM (Chomtho, Wells, Davies, Lucas, & Fewtrell, 2009).
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There are limitations to use of isotope dilution in the neonatal population. It can be
difficult to obtain appropriate saliva samples or urine sample, and a part of the isotope dosing
can be unsuccessful due to spilling/incomplete feeding (Wells, 2012). Isotope dilution is limited
in the first six weeks after birth, as urine output volume is smaller. Isotope dilution analysis
requires mass spectrometry or spectrophotometry, which is expensive and time consuming
(Wells, 2012). In addition, repeat measurements should only be conducted when the tracer from
the previous measurement has cleared the body, which is typically 10 to 14 days in infants (Ellis,
2007). The limitation of frequency of measurements is a clear disadvantage.
Air displacement plethysmography. Air displacement plethysmography (ADP)
calculates proportion body fat from body weight and volume by measuring bone density (Forsum
et al., 2016; Wells, 2012). Air displacement plethysmography provides a direct measurement of
body fat percentage (Kiger et al, 2016). Air displacement plethysmography for infants was
introduced in 2004 as the PEA POD (Forsum et al., 2016; Wells, 2012). The PEA POD can
accommodate infants from 1 kg to 8 kg and can tolerate moderate levels of infant activity (Wells,
2012). Air displacement plethysmography provides instantaneous results, is well tolerated by
infants, portable, and a noninvasive method that is ideal for serial measures to determine body
composition (McLeod et al., 2015; Roggero et al., 2012).
The accuracy and reliability of ADP to determine body composition in preterm infants is
argued among researchers. Air displacement plethysmography compared to DXA measurements
was found to have a strong correlation between methods to determine body composition in
preterm infants (Fields, Demerath, Pietrobelli, & Chandler-Laney, 2012). Direct confirmation of
ADP to accurately predict fat was found by examining live piglets with comparable weight of
VLBW infants and comparing them post mortem (Frondas-Chauty, Louveau, Le Huerou-Luron,
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Roze, & Darmaun, 2012). Air displacement plethysmography was sensitive in assessing the
preterm infant’s macronutrient and total energy intake on changes in body composition as early
as 31 weeks corrected gestational age (McLeod et al., 2015).
Roggero et al. (2012) examined preterm infant body composition comparing ADP with
reference H(2) 18O dilution method in 79 preterm infants and found ADP was accurate to
determine FM and interdevice reliability was strong (regression analysis, p < 0.001). Roggero et
al. (2012) used a two-component model based on total body water in order to calculate reference
estimates of body composition. It has been argued that a two-component model is not adequate
to examine body composition, as information regarding hydration and density of fat-free mass is
incomplete, and a three- or four-component model should be used (International Atomic Energy
Agency, 2009; Mcleod et al., 2015).
Forsum et al. (2016) performed the first validation study using a three-compartment
model in moderately preterm infants during the first week of life using the PEA POD to provide
estimates of FFM density and FM. The study found that individual estimates of FM may have
deviated significantly from the reference values and that FFM density values were biased;
however, the average estimates of FM were satisfactory (Forsum et al., 2016). Based on these
findings, the researchers argued that the PEA POD has not been appropriately validated to
determine body composition in preterm infants and requires further studies on the accuracy of
the PEA POD system (Forsum et al., 2016; McLeod et al., 2015).
There are other limitations in using ADP in the neonatal population. Air displacement
plethysmography is not widely available in NICUs (Kiger et al., 2016). Commonly cited reasons
ADP is not widely used in NICUs include medically instability, specialty calibrations for all
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equipment for each single infant use, convenience, cost, and personal preference of traditional
anthropometric methods (Kiger et al., 2016).
Predictive Measures
Bio-electrical impedance. Bio-electrical impedance (BIA) is a method to assess body
composition through measuring resistance or impedance of the body (Strydom et al., 2017). Bioelectrical impedance is performed by sending a weak alternating current at a fixed frequency
through the infant’s body (Collins et al., 2013). According to Strydom et al. (2017),
The measure of impedance is directly and inversely proportional to the volume of
conductor through which the current flows. In the human body the conductor is the total
body water (TBW), as it is almost entirely found in lean body mass (LBM). (p. 4)
As a result, FFM can be estimated by converting the measured resistance and used with the twocompartment model to estimate FM (Ellis, 2007). Fat mass and bone are resistant to bioelectrical impedance (Strydom et al., 2017). Bio-electrical impedance is inexpensive, simple,
quick, safe, and minimally invasive, and measurements can be made frequently and can be
completed at the bedside of a preterm infant without removal of respiratory support or
monitoring cords (Collins et al., 2013, Lingwood et al., 2012).
There are limitations for the use of BIA in the neonatal population. Wells (2012)
suggested that BIA is not appropriate in the neonatal population as is requires muscles to be in a
relaxed state, which is difficult to accomplish without sedation. Dung, Fusch, Armbrust, Jochum,
and Fusch (2007) reported that there is no clear evidence confirming the use of FFM prediction
equations in preterm neonates utilizing BIA. Raghavan et al. (1998) and Ellis (2000) found that
BIA did not have significant advantage over basic anthropometric length and weight measures in
infants.
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Skinfold thickness. Skinfold thickness measurements are obtained using caliper
measurements to determine neonatal local subcutaneous fat distribution and evaluate distribution
of FM in body regions (Strydom et al., 2017; Wells, 2012). Skinfold thickness measurements are
simple and an inexpensive method to determine body composition that can be performed at the
bedside (Simsek et al., 2015; Demerath & Fields, 2014).
There are limitations to use of in the neonatal population. Limitations include possible
invasiveness related to size of instruments compared to infant and possibly injuring the skin and
causing pain, specifically in extremely low birth weight (ELBW) infants with immature friable
skin (Strydom et al., 2017). Skinfold thickness measurements are significantly influenced by the
infant’s hydration status (Strydom et al., 2017). A preterm infant’s hydration status is not
constant, and sick infants can have extreme fluctuations in body water (Ellis, 2007; Strydom et
al., 2017; Ellis, 2007). Any body composition results obtained using indirect or direct measures
of body water with a two-compartment model should be done cautiously (Strydom et al., 2017).
Lastly, it is unknown whether the data obtained from skin fold thickness accurately informs
whole body fat measurements or total lean tissue in preterm infants (Wells, 2012).
Due to the concerns regarding the ability of skinfold thickness measures to accurately
inform whole body fat measures, an advanced method of combining skinfold thickness at two
primary sites and nine body dimensions, Dauncey anthropometric model, was developed. The
Dauncey anthropometric model uses skinfold thickness subscapular and triceps measurements;
circumference of the head, chest, abdomen at the umbilicus, mid-upper arm, mid-thigh, and midcalf; and lengths of the upper arm, lower arm, and crown-rump length (Dauncey, Gandy, &
Gairdner, 1977). The Dauncey anthropometric model has been considered one of the best
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methods to accurately determine body composition, specifically in resource poor countries
(Strydom et al., 2017).
Preterm versus Term Infant Body Composition
In a systematic review and meta-analysis examining body composition of preterm infants
at term equivalent age (TEA) compared to full term infants, TEA infants had greater percentage
total body fat, which was explained by lesser lean tissue rather than increase in FM (Johnson et
al., 2012). Preterm infants at TEA have similar FM to term infants. Preterm infants at TEA were
lighter, shorter, with a smaller head circumference compared to full term infants (Johnson et al.,
2012). Similarly, Gianni et al. (2016) examined body composition using ADP in late preterm
infants according to percentile at birth on day of life five and at term. Gianni et al. (2016)
reported that at birth, the preterm infant group had lower FM and FFM compared to term infants.
During the study, the FM and FFM increased significantly in the preterm infant group (Chisquared, p < 0.00001). At term, the FM index was significantly higher, but not FFM, in late
preterm infants compared to term reference infants (Chi-squared, p < 0.00001; Gianni et al.,
2016). As a result of more FM and less FFM, a higher total fat percentage occurs (Strydom et al.,
2017).
Delivery of Nutrition in the NICU
In this section, I will review how nutrition is delivered in the NICU. Nutrition
management in preterm infants can include parental nutrition, enteral nutrition, and/or oral
nutrition based on clinical condition and gestational age (Anderson, 2014). Lastly, I will briefly
explore demand feedings and the importance of frequency of feedings.
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Parental Nutrition
Parental nutrition provides nutrients intravenously and is standard of care for most
extremely preterm infants during first days of life (Anderson, 2014; Embleton & Simmer, 2014).
Parental nutrition is used to treat preterm infants that cannot be fed orally or enterally (Anderson,
2014; Koletzko, Goulet, Hunt, Krohn, & Shamir, 2005). Parental nutrition can provide glucose,
electrolytes, amino acids, and lipids (Embleton & Simmer, 2014). There is consensus that
extremely preterm infants or those weighing < 1,500 gram will benefit from parental nutrition
(Embleton & Simmer, 2014). It is unclear if days of life, weight gain, gestational age, and/or
physiologic stability, individually or in combination, are the optimal indicators to stop parental
nutrition (Embleton & Simmer, 2014). Many practitioners recommend parental nutrition in
preterm infants born < 32 weeks, weighing < 1,500 grams, and in more mature preterm infants
until full enteral feedings are established (Embleton & Simmer, 2014). Parental nutrition
commonly serves as an adjunct and bridge to enteral nutrition in preterm infants (Dutta et al.,
2015).
Parental nutrition should be started as soon as possible after birth on day of life one
(Embleton & Simmer, 2014). Despite this practice guideline, in a systematic review of literature
Lapillonne and Kermorvant-Duchemin (2013) reported that parental nutrition was only initiated
day of birth in 24% to 54% of respondents and 67% to 94% of respondents on day of life two.
There is a need for continued education among neonatal providers to reach compliance with
current practice guidelines.
Standardized parental nutrition is commonly initiated at birth and then individualized on
day of life two (Embleton & Simmer, 2014). Parental nutrition should be decreased as enteral
milk volumes are increased, and should not exceed total fluid intake of 15 – 175 mg/kg/day
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during the first few days of life (Embleton & Simmer, 2014). Parental nutrition should be
stopped once the preterm infant is tolerating enteral volumes of 125 – 150 ml/kg/day (Embleton
& Simmer, 2014). Bridging from parental nutrition to full enteral feeding is typically achieved in
one to two weeks and closely correlates with degree of prematurity (Embleton, Pang, & Cooke,
2001).
Enteral Nutrition
Enteral feedings provides nutrition directly into the gastrointestinal (GI) system via
nasogastric or orogastric tube (Anderson, 2014). Enteral nutrition is preferred to parental
nutrition, as it avoids complications secondary to vascular catheterization, sepsis, fasting, and
adverse effects of parental nutrition (Dutta et al., 2015). A primary nutritional goal when feeding
preterm infants is to reach full enteral feedings in the shortest time, while simultaneously
maintaining optimal growth and avoiding adverse effects of rapid feeding advancement
(Senterre, 2014). How to reach this goal is highly controversial.
Fresh mother’s milk is the preferable choice to begin enteral nutrition, followed by frozen
mother’s milk, pasteurized donor human milk, and preterm formula, respectively (Dutta et al.,
2015). It is acceptable to wait 24 to 48 hours for mother’s milk or PDHM to be available to start
minimal enteral feedings (Dutta et al., 2015). If mother’s milk or PDHM is not available at 48
hours, formula can be considered (Dutta et al., 2015).
Enteral nutrition should be initiated in ELBW and VLBW infants between six and 48
hours of life (Senterre, 2014), preferably within 24 hours of life (Dutta et al., 2015; Embleton et
al., 2017). Priming the GI system with colostrum is important to prevent GI mucosal dysfunction
and atrophy (Neu, 2007). In the NICU, enteral feedings are usually started as minimal enteral
feedings. Minimal enteral or trophic feedings are small feedings less or equal to 24 ml/kg/day to
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prime the gut and promote maturation of the GI system (Dutta et al., 2015; Neu, 2007). In a
systematic review, Morgan, Bombell, and McGuire (2013) found that early introduction of
enteral nutrition compared to fasting in VLBW infants correlated with reaching full feedings
earlier (mean difference − 1.05 days [95% CI −2.61, 0.51]).
Advancement of enteral nutrition should be individualized based on preterm infant body
weight and clinical condition (Senterre, 2014). A reasonable approach to advancing enteral
nutrition is by starting at 20 – 30 ml/kg/day in VLBW infants and increase by 30 ml/kg/day and
start at 15 – 25 ml/kg/day in ELBW infants and increase by 15 – 20 ml/kg/day (Dutta et al.,
2015; Koletzko et al., 2005). In a Cochrane review of VLBW infants, a slower daily increment of
15 – 20 ml/kg/day was compared to faster advancement of enteral feeding (30 – 35 ml/kg/day),
and the faster advancement reached full feeds and regained birth weight quicker and did not
increase mortality, necrotizing enterocolitis (NEC), or interruption of feedings (Morgan, Young,
& McGuire, 2014). Generally, full enteral feeds (150 – 180 ml/kg/day) are reached at day of life
14 in ELBW infants and by day life seven in VLBW infants in those that follow progressive
evidence-based feeding guidelines (Dutta et al., 2015).
The practice of delaying initiation or continuation of enteral nutrition is still observed in
NICUs (Senterre, 2014). Commonly cited reasons for withholding enteral nutrition include GI
immaturity, fear of NEC, perinatal asphyxia, lactic acidosis, patent ductus arteriosus requiring
indomethacin or Ibuprofen therapy, postnatal hemodynamic instability requiring inotrope
therapy, or presence of an umbilical arterial catheter (Hans, Pylipow, Long, Thureen, &
Georgieff, 2009; Klingenberg, Embleton, Jacobs, O’Connell, & Kuschel, 2011). There is no
strong evidence that withholding feedings during these clinical situations improves outcomes
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(Morgan, Bombell et al, 2013; Morgan, Young, & McGuire, 2013; Neu, 2014; Parker, Neu,
Torrazza, & Li, 2013).
In VLBW infants, delayed enteral nutrition is associated with a significant increase in
time to reach full enteral feeds, prolonged parental nutrition therapy and parental nutrition
associated morbidities, malnutrition, decreased weight gain, slower head growth, increased risk
for non-conjugated hyperbilirubinemia, nosocomial sepsis, metabolic disturbances, oxygen
needs, and longer time to discharge (Flidel-Rimon et al., 2004; McClure & Newell, 2000;
Morgan, Young et al., 2013; Rochow et al., 2012). Morgan, Young et al. (2013) reported in a
systematic review, that delaying enteral nutrition beyond four days of life did not decrease risk
for NEC in VLBW infants. The known contraindications to enteral nutrition includes intestinal
obstruction or ileus (Dutta et al., 2015).
Oral Feeding
There are no universal criteria when preterm infants can begin nonnutritive sucking and
feeding at the breast (Donath & Amir, 2008). Gestational age and postmenstrual age alone are
not reliable indicators of an infant’s suckling and feeding ability (Nyquist, 2008; Nyquist,
Sjoden, & Ewald, 1999). Nyquist and Ewald (1999) found in a study of 71 preterm infants born
between 27 and 36 weeks gestation that behaviors, including rooting, areolar grasp, and latch,
were achieved at 28 weeks postmenstrual age, and nutritive sucking was achieved at 31 weeks
postmenstrual age.
There is no evidence that it is required or advantageous to initiate oral feedings with a
bottle instead of at the breast (Hoban et al., 2015). Berger, Weintraub, Dollberg, Kopolovitz, and
Mandel (2009) reported that in 19 preterm infants born at 32 weeks gestation, there was no
difference in maternal milk intake or energy expenditure at the breast compared with bottle
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feeding. Casavant, Judge, and McGrath (2017) found that if the first oral feed was direct to the
breast, the infant would be more likely to still be receiving breastmilk at discharge. Encouraging
mothers to directly provide mother’s milk from the breast, in comparison to bottle feeding, can
increase likelihood to continue breastfeeding at discharge from the NICU (Briere, Mcgrath,
Cong, Brownell, & Cusson, 2015; Casavant et al., 2017).
Demand Feedings
The concept of preterm infant initiated feedings (demand feedings) in response to hunger
and satiation cues has promising future when compared to scheduled interval feedings in the
NICU. The current practice in the United States is that preterm infants experience scheduled
interval feedings (Watson & McGuire, 2016). It is not known if this is an optimal nutrition
practice. Watson and McGuire (2016) reported that demand or semi-demand feedings were
correlated with earlier achievement of full oral feedings, increased nutrient intake and growth
rates, and earlier discharge from the NICU at an average of two to four days.
Semi-demand feedings allow the caregiver to recognize and respond to feeding cues.
Semi-demand feeding includes a prescribed 24 hour minimal milk intake (Watson & McGuire,
2016). In general, the prescribed 24 hour milk intake requirement is divided over six to eight
hour timeframes. If the infant does not consume the minimum feeding at the breast during that
designated time, as evidenced by pre/post feeding weight, the remaining milk volume is
administered at the end of the time interval (Watson & McGuire, 2016).
Types of Nutrition
In this section, I will review the types of preterm infant nutrition delivered in the NICU.
The types of enteral or oral nutrition that preterm infants may receive, human milk (mothers own
milk and/or PDHM) and/or formula, will be reviewed.

40

Human Milk
Human milk composition has been biologically adapted throughout existence to meet the
nutritional and immunological requirements of infants (Riordan & Wambach, 2010). Human
milk includes mother’s own milk (MOM) or pasteurized donor human milk.
Composition of human milk. Breast milk is a vital source of not only infant nutrition
but immune modulating bioactive components to support infant growth and health (Andreas,
Kampmann, & Le-Doare, 2015; Martin, Ling, & Blackburn, 2016). Composition of human milk
is highly variable and can change within a single feeding or differ between breasts, influenced by
diurnal patterns, exclusivity, postnatal age, gestational stage, and within storage and
pasteurization of expressed human milk (Riordan & Wambach, 2010). The primary components
of human milk include water, lipids, lactose, and protein (Andreas et al., 2015). Secondary
components include vitamins, minerals, and bioactive/immune modulating components (Andreas
et al., 2015; Martin et al., 2016).
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Table 1.
Composition of Major Components of Human Milk
Component





Lipids



Lactose




Protein




Composition
40% to 55% of energy supplied from human milk (Andreas et al., 2015;
Guo, 2014).
Most variable constituent (Kent, 2007).
Inverse relationship with degree of breast fullness (Kent, 2007).
Maternal diet does not affect the total amount of fat found in human
milk; however, the habitual dietary intake of fatty acids is the primary
influence on the composition of lipid content with most milk fat (98% to
99%) being comprised of triglycerides (Antonkou et al., 2013).
40% of energy that is supplied from breast milk (Guo, 2014).
Helps in absorption of iron and calcium in the breastfed infant (Martin et
al., 2016).
Plays a crucial role in corresponding to the high energy demands of the
infant brain (Andreas et al., 2015).
Very low protein content, as it is species-specific and meets the needs of
immature kidneys and liver in the human neonate that cannot yet process
a high protein milk.
Roles in immunomodulatory and antimicrobial effects (Andreas et al.,
20152015).
The primary source of protein in human milk is synthesized by the
lactocyte, and the remaining 10% to 20% of protein is obtained via
transcytosis from maternal circulation (Andreas et al., 2015).

Mother’s own milk. Mother’s own milk is defined as human milk provided by the
infant’s biological mother. Mother’s own milk is the food of choice for all preterm infants
(Krolak-Olejnik & Czosnykowska-Lukacka, 2017). Mother’s own milk contains many bioactive
components that are mother-specific, including human milk microbiome probiotic bacteria and
prebiotic oligosaccharides (Collado et al., 2015; Underwood et al., 2015). When MOM is not
available, PDHM is recommended as a suitable alternative superior to formula (Arslanoglu,
Ziegler, & Moro, 2010). Mother’s own milk is unique in providing immunoprotection via
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antibodies that may be reduced in pasteurization compared to PDHM (Boyd, Quigley, &
Brocklehurst, 2007; Tudehope, 2013).
Pasteurized donor human milk. There are many reasons in which MOM is not
available or is contraindicated, including maternal disease/surgery/death, maternal use of drugs
or certain medications, inadequate supply, cost, or mother’s preference. For those mothers of
preterm infants that are unable to provide mother’s milk, PDHM is a great alternative that offers
similar health protections to mother’s milk (Vongbhavit & Underwood, 2016). Pasteurized donor
human milk utilized in NICUs is human milk supplied by lactating women that is screened and
pasteurized at a human milk bank (Arslanoglu et al., 2010). Pasteurization of human milk
removes potentially harmful viruses and bacteria, but also alters important protective
immunologic and anti-infective properties, including lipase, lymphocytes, immunoglobulin G
(Arslanoglu et al., 2010, Boyd et al., 2007; Tudehope, 2013). As a result of pasteurization, it
cannot be assumed that PDHM has the same protections as MOM (Boyd et al., 2007).
Researchers have reported that up to 72% of all mothers of very preterm infants in the
NICU were unable to provide all mother’s milk needed for an exclusive human milk (EHM) diet
(Carroll and Herrmann, 2013). Pasteurized donor human milk used to supplement or replace
MOM is strongly associated with decreased preterm infant morbidity (Edwards & Spatz, 2012).
There is reduced risk for feeding intolerance, NEC, nosocomial infections, respiratory disease,
and feeding intolerance with use of PDHM compared to formula (Edwards & Spatz 2012). Kim,
Lee, and Chung (2017) found that preterm infants who received a PDHM diet were more likely
to reach full feedings earlier compared to formula fed infants (29.6 ± 12.0 vs 52.2 ± 17.6 days).
Comparison of donor milk: full term versus preterm. Postnatal age and gestational
stage are important predictors of human milk content. Gidrewicz and Fenton (2014) found that in
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comparison of term human milk to preterm human milk, there were statically significant
differences in human milk composition, with exception of fat and calculated energy. Human
milk bioactive proteins with anti-infective, immune, and neuroendocrine properties and including
IgA, lysozyme, and adiponectin were higher in preterm transitional breast milk than in term
breast milk (Mehta & Petrova, 2010). Lactoferrin, osteoprotegerin, and leptin were higher in
term transitional human milk than in preterm human milk (regression analysis, p < 0.05 to
0.0001; Mehta & Petrova, 2010).
There are significant differences in bioactive and true proteins between preterm and term
human milk (Gidrewicz & Fenton, 2014; Hsu et al., 2014; Mehta & Petrova, 2010). True protein
content in preterm human milk is higher than term milk, with up to 35% difference in true
protein content within the first three days of life (Gidrewicz & Fenton, 2014). As postpartum age
increases, the difference in true protein content between preterm and term human milk becomes
similar within 0.2 g/dL by postpartum day three and the same by weeks 10 to 12 (Gidrewicz &
Fenton, 2014). Similarly, Radmacher, Lewis, & Adamkin (2013) found when examining
macronutrient content using mid-infrared spectrophotometry, term donor milk had protein
concentration of 1 g/dL and 15 kcal/oz compared to preterm mother’s milk protein concentration
of 1.4 g/dL and 19 kcal/oz. Preterm mother’s milk protein changed according to week of
lactation, declining over the first three months; however, it was always statistically greater than
that found in PDHM (Radmacher et al., 2013).
Formula
While formula substitution efforts have been made, the immunological benefits of human
milk have not been duplicated (Ridoran & Wambach, 2010). Formula is an appropriate option
for preterm infant nutrition when MOM and PDHM is not available (Tudehope, Page, & Gilroy,
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2012). Formula has been commercially designed to provide nutrition that will result in matching
intrauterine growth (Tudehope et al., 2012). Preterm infant formula typically provides 80 to 82
kcal/100 mL protein (Tudehope et al., 2012). Formula can offer an advantage of predictable
uniform composition.
Despite the known benefits of EHM feedings, health care providers caring for preterm
infants continue to supplement human milk with formula to maximize growth acceleration (Hay
& Hendrickson, 2017). In a meta-analysis, Wagner (2013) found an average daily weight gain of
2.7 – 3.8 gm/kg greater in preterm infants fed preterm infant formula compared to PDHM fed
infants. A Cochrane review examined over 1,000 VLWB infants and compared growth with
formula and PDHM (Quigley & McGuire, 2014). In four studies, Quigley and McGuire (2014)
compared term formula and PDHM, and in five studies, compared preterm infant formula and
pasteurized donor human milk. In only two of these studies, PDHM was fortified. The formula
fed preterm infants had higher growth rates for head circumference, length, and weight in all
studies (Quigley & McGuire, 2014). Formula in comparison to human milk lacks active enzymes
that improve maturation of the preterm gut and anti-infective properties. Formula use in the
preterm infant is correlated with later advancement of full enteral feedings, increased risk of
NEC, increased duration of parental nutrition, and increased length of NICU stay (Boyd et al.,
2007; Hay & Hendrickson, 2017; Quigley, Henderson, & Anthony, 2007).
Fortification of Human Milk
In this section, I will review fortification of human milk. I will examine types of fortifier,
fortification methods, and lactoengineering.
Not all research clearly supports fortification of human milk in preterm infants; however,
many researchers and neonatal providers argue that MOM and/or PDHM requires fortification to
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meet the high nutrient needs in order for preterm infants to achieve optimal growth velocity
(McLeod and Sherriff, 2007; Radmacher & Adamkin, 2017; Reali et al., 2015; Schanler, Lau,
Hurst, & Smith, 2005). When preterm infants are born in the early third trimester, they miss the
placental transfer of nutrients that normally serve as stores for use postnatally (Henriksen et al.,
2009). Fortification may provide supplementation of these missing nutritional stores.
The practical guidelines for nutritional care of preterm infants recommends fortification
of human milk in both ELBW and VLBW infants prior to reaching 100 mL/kg/day (Senterre,
2014) at a concentration of 1:50 (Dutta et al., 2015). The AAP (2012) recommend that all
preterm infants born with a birth weight < 1,500 grams should be fed fortified human milk. The
European Society of Paediatric Gastroenteroly, Hepatology, and Nutrition (ESPGHAN)
recommends that all preterm infants born with a birth weight less < 1,800 grams should be fed
fortified human milk (Agostoni, Buonocore, Carnielli et al., 2010). Fortification of human milk
should include proteins, vitamins, and minerals (AAP, 2012; Agostoni et al., 2010). There is not
a recommendation made when to stop fortification.
Some researchers argue that unfortified human milk is commonly deficient in at least one
or a combination of the three macronutrients: protein, carbohydrates, or fat (Rochow et al.,
2013). The primary nutrient deficiency reported in human milk is inadequate protein and energy
(kcal) concentration (Arslanoglu, Moro & Zeigler, 2006; Krcho, Vojtova, & Benesova, 2015).
The difference between the mean energy concentration of unfortified and fortified preterm
human milk was 7.897 kcal/L (Krocho et al., 2015). However, preterm infants fed MOM or
PDHM with human milk fortifier, compared to infant formula, may have decreased protein
needs, as the bioavailability is greater in fortified human milk (McLeod and Sherriff, 2007).

46

Two types of fortification are readily available, including donor human milk-based fortifier or a
bovine milk-based fortifier.
Types of Fortifier
Donor human milk-based fortifier. Donor human milk based fortifier (Prolacta) is
derived from pooled human milk and is available in a variety of products, ranging from 24 cal/oz
to 30 cal/oz and can supplement electrolytes and minerals (Radmacher & Adamkin, 2017).
Donor human milk-based fortifiers support an EHM diet and have significant implications that
may decrease risk for morbidity, mortality, and healthcare costs. Sullivan et al. (2010) reported
that preterm infants fed a donor human milk-based fortified human milk diet, compared to those
fed bovine-based fortified human milk diet, had a 50% decreased risk for NEC and an 80%
decreased risk for requiring surgery secondary to NEC.
Bovine milk-based fortifier. Bovine milk-based fortifier (Enfamil Human Milk
fortifier/Similac Human Milk Fortifier) is derived from bovine milk protein and is available in a
variety that can add an additional 1.4 g to 2.2 g of protein when four packets are added to 100
mL of human milk (Radmacher & Adamkin, 2017). Bovine fortifier is the most commonly used
fortifier in NICUs due to cost. Use of bovine fortifier in human milk exposes the infant to nonhuman milk protein and is associated with serious health issues, including increased risk of NEC,
respiratory infection, sepsis, and overall reduced survival (Sullivan et al., 2010).
The literature describes three nutritional approaches in human milk fortification: standard
fixed dose fortification, adjustable fortification using blood urea nitrogen (BUN) to modify
fortification dose, and targeted/individualized fortification based on human milk analysis, with
supplementation of specific macronutrients as needed. The optimal methods of fortification when
required remain uncertain. The available data suggest that if fortification is required, adhering to
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an EHM diet with donor human milk derived fortifier can result in appropriate growth and
reduce morbidity and mortality (Abrams, Schanler, Lee Martin, Rechtman, & Prolacta Study
Group, 2014).
Fortification Methods
There are two methods of fortification, including standard fortification and individualized
fortification. Individual fortification includes two subtypes: adjustable fortification and targeted
fortification.
Standard fortification. Standard fortification is the most commonly used method for
human milk fortification in NICUs (Radmacher & Adamkin, 2017). The current consensus
statement on human milk feeding in preterm infants recommends that fortification begins with
standard fortification, with advancement to individualized fortification only if growth is
inappropriate (Moro, Arslanoglu, Bertino et al., 2015). Standard fortification is based on the
assumption that human milk has a protein content of 1.5 g/dL (Radmacher & Adamkin, 2017). A
fixed dose of fortifier is added to human milk. Standard fortification does not take into account
any caloric or nutrient changes that may occur in the human milk being fortified (Radmacher &
Adamkin, 2017).
Some researchers argue that preterm infants fed human milk with standard fortification
may not meet the recommended nutrient intake in VLBW infants (Rochow et al., 2013).
Arslangoglu et al. (2006) found that standard fortification of human milk with bovine fortifier
can still be a deficit in protein intake and lead to slower growth than those fed equicaloric
formulas. Henriksen et al. (2009) found that in 127 VLBW infants fed preterm mother’s milk or
donor human milk with standard fortification at 120 ml/k/day still demonstrated growth failure at
discharge, defined as body weight less than the 10th percentile, in 58% of the sample. In
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contrast, Ginovart, Gich, Gutierrez, and Verd (2017) examined weight gain and head growth in
VLBW preterm infants fed standard fortified (80 ml/kg/day) MOM or PDHM compared to
formula fed infants, and extrauterine growth was significantly greater in the infants fed the
standardized fortified human milk diet.
Adjustable fortification. Adjustable fortification utilizes preterm infant BUN level to
modify fortification dose (Radmacher & Adamkin, 2017). The BUN measures serve as a proxy
for assessing adequate protein intake (Radmacher & Adamkin, 2017). The amount of fortifier
added to human milk is dependent on changes in serial BUN measurements obtained twiceweekly (Arslanoglu et al., 2006). If BUN is lower than threshold, additional fortifier is
supplemented, and if BUN is greater than desired, the amount of fortifier is reduced (Radmacher
& Adamkin, 2017).
Arslanoglu et al. (2006) found adjustable fortification with bovine fortifier and aggressive
protein supplementation based on infant BUN levels superior, with significantly greater growth
(weight, head circumference, and growth velocity) compared to standard fortification (bovine
fortification of 5g/100ml of human milk). Adjustable fortification with bovine fortifier had an
average growth velocity of 17.5 + 3.2 gm/kg/day compared to standard fortification with bovine
fortifier 14.4 + 2.7 gm/kg/day (Arslanoglu et al., 2006). Arslanoglu et al. (2006) reported that the
consequence of standard fortification was protein under nutrition resulting in decreased growth.
Targeted fortification. Targeted fortification utilizes human milk analysis to inform
providers what type of supplementation is needed to closely match an infant’s diet with
nutritional needs for adequate growth and development (Radmacher & Adamkin, 2017).
Targeted fortification can be accomplished by addition of fortifiers or lactoengineering of milk.
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With use of fortifiers, the preterm infants recent growth rate on the current fortification regime
and macronutrient analysis of human milk are taken into consideration (Radmacher & Adamkin,
2017). Studies have shown that targeted fortification of human milk provides increased protein
and is correlated with exceeding the expected growth velocity of 15 gm/kg/day, improving short
term weight gain, and increasing linear growth (Hair et al., 2014, Reali et al. 2015; Rochow et
al., 2013).
Lactoengineering
Lactoengineering of human milk is an alternative to fortification of human milk.
Lactoengineering utilizes high fat milk cream that rises to the top of the milk sample (Hair et al.,
2014; Ogechi et al., 2007, Slusher et al., 2003). The high fat cream is skimmed off the top to be
provided to the infant to increase fat and energy content (Hair et al., 2014). Engineering human
milk with human milk-derived cream supplement using the Creamatocrit technique can provide
energy dense feedings without substantial increase in the total volume of feeds (Hair et al.,
2014). Hair et al. (2014) found in a randomized control trial, when VLBW infants are given
MOM or PDHM lactoengineered with human milk-derived cream product, compared with
standard bovine milk fortifier, the human milk-derived cream product had significantly enhanced
growth velocity. Infants who received human milk-derived cream product had an average growth
velocity of 14.0 gm/kg/day (Hair et al., 2014). Infants who received standard bovine milkfortified diet had an average growth velocity of 12.4 gm/kg/ day (Hair et al., 2014).
Cost of Human Milk Use in the NICU
In this section, I review cost of human milk use in the NICU. I specifically examine the
potential cost savings attributed to use of human milk in the NICU by decreasing preterm infant
morbidity/mortality risk (Buckle & Taylor, 2017).
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The AAP (2017) reported that use of PDHM is limited by availability and purchase cost.
Hospitals that use banked donor milk generally have minimal budgets allocated for purchase of
donor milk (National Breastfeeding Center, 2016). Donor human milk costs on average $4.50 per
ounce incurred as processing fee (Huertas, 2015; Spatz, Robinson, & Froh, 2017). The
processing fee covers costs to screen potential donors, including laboratory costs, processing
human milk, shipping, supplies, and general overhead incurred in running a nonprofit milk bank
(Spatz et al., 2017). However, for every $1.00 spent on pasteurized donor human milk, there is a
potential saving up to $11.00 in medical costs of the preterm infant (Huertas, 2015).
The potential long-term cost savings by adhering to an EHM diet and avoiding bovine
fortifier and bovine formula is profound among preterm infants in the NICU. In avoidance of
NEC alone, Ganapathy, Hay, and Kim (2012) reported a lower expected NICU length of stay of
3.9 NICU days and reduced total expected costs of hospitalization with a net direct average
savings of $8,167.17 per extremely premature infant (multivariate regression, p < 0.0001).
Buckle and Taylor (2017) stated that the estimated increased incremental length of stay
associated with NEC was 18 days for medical management of NEC and 50 days for management
of surgical NEC. Necrotizing enterocolitis is among the highest per case cost for commercial
insurance and Medicaid and a huge cost driver in NICUs (Bisquera, Cooper, & Berseth, 2002).
Necrotizing enterocolitis accounts for 19% of NICU expenditures and $5 billion per year in
hospitalization costs (Bisquera et al., 2002). Human milk is the only treatment known to reduce
the incidence of NEC (Bisquera et al., 2002). Human milk reduces risk for NEC by 77%
(Bisquera et al., 2002). Future research should include full economic evaluation to examine
longitudinal outcomes related to preterm infant nutrition cost and morbidity/mortality risk
(Buckle & Taylor, 2017).
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Current Recommendations for Preterm Infant Feeding and Growth
Human milk is regarded as the superior and preferred feeding method for hospitalized
preterm infants (Menon & Williams, 2013). All preterm infants should receive human milk, and
if MOM is not available or contraindicated, PDHM should be used (AAP, 2012). Preterm infants
who are clinically stable and able to breastfeed should be introduced to the breast as soon as
possible and exclusively breastfed for six months (AAP, 2012). Exclusive human milk diet in the
hospitalized extremely preterm infant is associated with lower risks of death, NEC, and sepsis
(Abrams et al., 2014). Exclusive human milk diet for preterm infants has been identified as one
of the most influential preventative treatments available in NICUs that reduce infant morbidity
and mortality (National Breastfeeding Center, 2016).
Body composition is a key metric when assessing nutrition in preterm infants; however,
widespread use body composition measures in NICUs are limited due to cost and feasibility
(Kiger et al., 2016). Due to these limitations, anthropometric measures are very useful and a
necessary tool for neonatal care providers in prescribing preterm infant nutrition (Kiger et al.,
2016). Accurate daily weights, weekly lengths and head circumferences should be obtained in all
hospitalized preterm infants (Anderson, 2014; Greer & Olsen, 2013; Poindexter, 2014). These
measures should be plotted on a standardized growth chart at the same time each week during the
NICU stay to inform nutritional practices (Anderson, 2014, Greer & Olsen, 2013; McLeod &
Sherriff, 2007).
Gaps in Knowledge
The current state of the science on preterm infant growth and nutrition does not provide
researchers or clinicians with sufficient data to determine optimal growth for each individual
infant (Embleton et al., 2017). Preterm infant growth is multifactorial based on maternal and

52

infant physiological, developmental, genetic, nutritional, and environmental factors that can
greatly differ between each infant. It is apparent that an intrauterine rate of growth for one
preterm may be sufficient, but a slower trajectory may be more appropriate for a different infant
(Embleton et al., 2017). Further research studies are needed to address if NICU growth velocity
goals should be redefined. The failure of many infants to achieve the desired growth velocity
may indicate inadequacy of the current standard.
Nutritional management of preterm infants is marked by a lack of practice uniformity
(Wight et al., 2008). Despite existing standardized feeding guidelines there continues to be
significant heterogeneity within and between NICUs in type, timing, and frequency in delivery
of preterm infant nutrition from the first hour of life to NICU discharge (Ehrenkranz, 2014;
Wight et al., 2008). Interventions for preterm infants that utilize standardized feeding protocols
are not well represented in the literature (Butler et al., 2013). Future research should include
specific nutrient and fortification composition to promote growth.
There is not a clear understanding of the consequences of rapid growth. It is possible that
lower nutrient intake and slower growth may be protective longitudinally (Embleton et al.,
2017). Future research is needed to examine the relationship between fetal and neonatal growth
and alteration of subsequent metabolic and cardiac function to prevent risk for harm later in life.
Summary
It is unclear what optimal growth and associated nutrition is for preterm infants. It is
possible that if a preterm infant’s growth appears stable and is moving appropriately across
percentiles, and there is no underlying contributing pathology, then quite possibly, this may be
optimal (Embleton et al., 2017). What is clearly known is that preterm infants fed an EHM diet
demonstrate improved morbidity compared to formula fed infants (National Breastfeeding
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Center, 2016). Despite many uncertainties in neonatal growth and nutrition, there is a clear
relationship between improved health outcomes and a protective dose response relationship with
the duration and/or exclusivity of human milk (Embleton et al., 2017). More attention needs to
be focused on the quality of growth through optimal nutrition management (McLeod & Sherriff,
2007).
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Chapter IV: Methodology
Research Design
A retrospective, descriptive, correlational study was conducted comparing growth of
VLBW hospitalized preterm infants by proportion of human milk intake. The study was
performed at a level three neonatal intensive care unit in a small urban community in southeast
Wisconsin that serves an economically and racially/ethnically diverse community.
Sample
The participants consisted of a convenience sample of VLBW preterm infants. Inclusion
criteria included infants born < 1500 gm by vaginal or cesarean birth at study hospital or
transferred to study hospital within 12 hours of birth. The exclusion criteria were as follows:
infants who died or were transferred prior to reaching full enteral feedings or infants born with
visible structural congenital anomalies due to their potential for special nutritional needs and
additional health concerns. Visible congenital anomalies were identified according to the
International Classification of Diseases found in the problem list of the infant’s chart.
Participants included 143 preterm infants with birth weights < 1500 gm admitted to the study
hospital by birth or transferred within 12 hours after birth. Three infants were excluded for
congenital anomalies, 36 infants died, and 22 infants were transferred to a different hospital
before reaching full enteral feeding and were excluded from the study. The data from the
remaining 82 infants were analyzed.
Power analysis with the 82 infants available for statistical correlational analysis revealed
the study was underpowered. Power analysis with an alpha of 0.5, medium effect 0.25, n=82
resulted in a power of .63. While the results of the study may not have been statistically
significant, it was felt there would be clinical significance and would be acknowledged as a
limitation of the study. The sample size at this single site was not able to be increased as there
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was a change in electronic health record (EHR) systems and the data was unavailable for
abstraction.
Procedure
Data were abstracted from the EHR from the sample population based on inclusion and
exclusion criteria. Data collection forms were created for the purpose of this study to abstract
participant characteristics and clinical measures. Data collection was conducted for each subject
until full enteral feedings were reached. Data were stored in an electronic format on a passwordprotected computer. To examine the data for accuracy, the primary investigator performed
double data entry on a random sample of 10 cases to check for degree of accuracy compared to
original data, and there was 100% agreement.
Protection of Human Subjects
Institutional Review Board (IRB) approval was obtained prior to data collection from the
hospital system as the IRB of record and through an agreement with University of Wisconsin
Milwaukee IRB. Expedited review and waiver of informed consent was granted because there
was minimal risk to infants participating in the retrospective chart review. The primary
investigator completed appropriate IRB modules through CITI.
Measurements/Variables
Demographic variables. Demographic variables obtained were race, sex, and type of
gestation (singleton or multiple).
Day of life one. Day of life one was measured as day of birth.
Day of first enteral feeding. Day of first enteral feeding was measured as the day of life
that enteral feeding was initiated.
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Gestational age. Gestational age was measured by prenatal ultrasound obtained before
20 weeks and/or number of weeks dating from the first day of the mother’s last menstrual period
and/or and infant assessment. Gestational age was measured at birth.
Time to full enteral feeding. Time to full enteral feeding was measured in number of
days from day of life one (birth) to 72 hours after the last intake of total parental nutrition (TPN)
or parental fluids. Each day of life was measured in calendar days from hours 0000 to 2400.
Time to full enteral feeding was measured as 72 hours after last intake of TPN of parental fluid
intake to ensure the infant would successfully tolerate the transition of increased enteral feedings.
Type and amount of nutritional intake. Human milk intake refers to MOM and
pasteurized donor human milk. All intake that is not human milk intake is considered preterm
infant formula. Mother’s own milk refers to human milk produced by the mother of the preterm
infant. Pasteurized donor human milk (PDHM) refers to human milk expressed by milk donors
and provided by Mother’s Milk Bank of Western Great Lakes. Both preterm and term PDHM
were available at the hospital of study, however, the EHR does not indicate what type of PDHM
was used in each individual infant or at each individual feeding. Nutritional intake was
abstracted for each feeding separately until the infant reached full enteral feedings.
Fortification of Pasteurized Donor Human Milk. Fortification of PDHM was
performed with standard fortification, adding a fixed dose commercial fortifier to human milk.
There was not a standardized protocol for fortification initiation and advancement used at this
study site and varied among provider preference.
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Figure 3. Stratification of type of nutritional intake.
Volume of enteral intake at time of human milk fortification. In the subgroup of
infants who experienced fortification of human milk, volume of enteral intake at the time of
fortification initiation was abstracted. Volume of enteral intake was calculated as mL/kg/day on
the day fortification was initiated.
Growth velocity. Growth velocity is a measure used to summarize infant weight gain
over a specific time interval (Patel et al., 2009). Estimated growth velocity (gm/kilogram/day)
was measured using an exponential model (EM). The EM is validated for use in VLBW infants
to examine growth (Patel et al., 2009). The EM (W= weight in grams, D= day, 1 beginning time
interval and n = end of time interval in days) is:
GV = [1000 × ln(Wn/W1)]/(Dn − D1)
Growth velocity at time of human milk fortification. In the subgroup of infants who
experienced fortification of human milk, growth velocity (gm/kg/day) was examined at the time
of fortification initiation.
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Growth by feeding type. Growth velocity (gm/kg/day) for postmenstrual age from birth
through full feeding was measured by quantity of human milk intake. Subgroup analysis of
growth based on feeding type was performed between mother’ own milk, pasteurized donor

Growth Velocity (gm/kg/day)

human milk, fortified MOM, and PDHM (see Figure 4).

% of Human Milk Intake

Figure 4. Growth velocity by percent of human milk intake
Weight. Weight was recorded as measured in the EHR. Weight is measured at this
facility using the Olympic Smart Scale. The Olympic Smart Scale provides an electronic
biophysical objective measure of weight in grams. The Olympic Smart Scale is a reliable and
valid measure of preterm infant weight for calculation of medications, parental fluids, and
nutritional requirements (Engstrom et al., 1995). Engstrom et al. (1995) determined reliability by
obtaining two weight measurements by two nurses for each infant (N=32) for three consecutive
days. The intraexaminer reliability was determined by examining the difference between each
nurse’s weight measurements. The average mean absolute difference between individual nurse’s
weight measurements was 12.58 grams for weights obtained in the incubator and 19.19 grams for
weights obtained with the radiant warmer (Engstrom et al., 1995). The interexaminer reliability
was determined by examining the difference between the pairs of nurses’ weight measurements.
The average mean absolute difference was 14.29 grams for weights obtained in the incubator and
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24.42 grams for weights obtained with the radiant warmer (Engstrom et al., 1995). According to
the NICU policy at the institution of study, weight should be measured on day of life one and,
thereafter, every 3 days until discharge from the NICU.
Suboptimal growth. Suboptimal growth was measured as growth velocity less than 15
gm/kg/day.
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Table 2.
Measure and Data Management Chart
Research Question
What is the growth
velocity
(gm/kg/day) of
VLBW preterm
infants at the time
human milk
fortification is
initiated?

Variable
IV- time of human
milk fortification
DV- growth
velocity

Measurement
Time of human milk fortification
initiation= day of life that human
milk fortification was initiated
GV = [1000 × ln(Wn/W1)]/(Dn −
D1)
W= weight in grams
D= day, 1 beginning time
interval
n= end of time interval in days

Level of
Measurement
Time of human
milk fortification
initiation- interval

Statistical Test
Descriptive
analysis

Growth velocity
(gm/kg/day)interval level.

Weights as they were obtained
every 1-5 days will be used to
calculate GV. These GV values
will then be averaged over the
NICU time to full feedings to
yield the overall GV.
Is there a
relationship
between growth
velocity
(gm/kg/day) of
VLBW preterm
infants from birth to
full feeding and
percentage of
human milk intake?

IV- percentage of
human milk intake
DV- growth
velocity
(gm/kg/day)

% of human milk intake=
human milk intake/ total intake
GV = [1000 × ln(Wn/W1)]/(Dn −
D1)

Percentage of
human milk
intake- interval
Growth velocity
(gm/kg/day)interval

Correlational
analysis

Is there a
relationship
between growth
velocity
(gm/kg/day) of
VLBW preterm
infants from birth to
full feeding and
percentage of
mother's own milk,
pasteurized donor
milk, and mixed
donor/ mother's own
milk intake?

IV- percentage of
mother's own milk,
pasteurized donor
milk, and mixed
donor/ mother's own
milk intake
DV- growth
velocity
(gm/kg/day)

% of human milk intake=
human milk intake/ total intake

Percentage of
human milk
intake- interval

Correlational
analysis

What is the volume
of enteral intake
(mL/kg/day) at the
time human milk
fortification is

IV- time of human
milk fortification

Time of human milk
fortification= day of life that
human milk fortification was
initiated
Volume of enteral intake

DV- volume of
enteral intake

GV = [1000 × ln(Wn/W1)]/(Dn −
D1)
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Growth velocity
(gm/kg/day)interval

Time of human
milk fortificationinterval
Volume of enteral

Descriptive
analysis

initiated?

(mL/kg/day)

intake- interval

What is the average
day of life when
birth weight is
regained?

Descriptive- day
life birth weight is
regained

Day of life that when birth
weight is regained

Day of lifeinterval

Descriptive
analysis

What is the average
day of life that
enteral feedings are
initiated?

Descriptive- day of
life that enteral
feedings are
initiated

Day of life when enteral
feedings are initiated

Day of lifeinterval

Descriptive
analysis

What percentage of
infants experience
sub-optimal growth
as measured by a
growth velocity <
15gm/kg/day when
reaching full
feedings in the
NICU?

Descriptivepercentage of
infants with
suboptimal growth

% of sample with growth
velocity less than 15gm/kg/day
when reaching full feedings

% of sample with
growth velocity
less than
15gm/kg/day ratio

Descriptive
analysis

Data Management Plan
The primary investigator acted as the data manager with the biostatistician when
implementing the data management plan. A biostatistician provided consultation during data
analysis. The data management plan included the following steps:
1. All patients were coded to ensure confidentiality. A list of patient name and MRN
were coded to a subject number and maintained during the study. The file was
electronic password-protected. Subject identification numbers (ID) were used with
data collected from patient charts. These were stored in an electronic format on a
password-protected computer for only study personnel to access. Study data was only
made available to study investigators.
2. The primary investigator entered all the data into a password-protected database in
SPSS® statistics 23 and created a code book.
3. The data was screened for errors. First, data was checked to make sure all scores were
not out of range for each categorical and continuous variable using SPSS®
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statistics 23. Errors were corrected. The process was repeated until there was
confidence that the data was clean. A log book of all errors in the data were recorded.
4. After 25% of the data was abstracted and entered, the sample demographics were
checked for errors or skew and assumptions were checked.
5. Data was appropriate and assumptions were met and the remaining data was
abstracted and analyzed.
6. The data file was examined for missing data. Descriptives were run to examine what
percentage of values were missing in each variable. Missing data was checked for
patterns. Missing values were managed by excluding cases pairwise. By excluding
cases pairwise, the subject was only excluded if the data was required for a specific
analysis ran. The subject was included in any analysis where they had the required
data. This was beneficial to keep sample size adequate.
7. The statistical team at the university of study, methodological experts, and the
primary investigator collaborated and discussed any issues and need for
modifications.
Analysis
Participant characteristics and clinical variables were analyzed for frequencies, frequency
distributions, percentages, mean, median, and standard deviation. The descriptive statistics of
these variables were examined for skewness, kurtosis, normality, and missing data. The
descriptive statistics were used to describe the characteristics of the sample and address all
research questions.
All analyses were performed using SPSS® statistics 23. Initially, descriptive statistics
were analyzed. Frequencies, frequency distributions, and percentages were run on categorical
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variables. Descriptive statistics, including frequencies, mean, median, and standard deviation,
were run on the descriptive variables. The descriptive statistics of these variables were examined
for skewness, kurtosis, normality, and missing data. The descriptive statistics were used to
describe the characteristics of the sample and to address the descriptive research questions.
To examine the non-descriptive research questions, a correlation was performed. A
correlation is an appropriate statistical test, as the purpose of the research was to explore the
strength of the relationship between percent of human milk intake (continuous variable) and
growth velocity (continuous variable).
The assumptions for correlation and Pearson product-moment correlation coefficient
were checked for violations, including level of measurement, related pairs, normality, linearity,
and homogeneity of variance. The level of measurement was met, as both variables are
continuous. Related pairs were met, as each participant had a pair of values for each variable.
Normality was examined with the Komogorov-Smirnov test. There was not a Sig. value less than
0.70, indicating normality. Lastly, linearity and homoscedasticity were examined. Linearity and
homoscedasticity were not met. The shape of the values formed by the scatterplot were nonlinear
in a blob-type arrangement. After consideration and discussion with a biostatitisican, it was
decided to abandon correlation analysis and to move forward with analysis of the descriptive
research questions.
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Chapter V: Study Results
The objective of this study was to examine how feeding practices impact growth in
hospitalized preterm infants < 1500 grams from birth until reaching full enteral feedings. In
addition, this study explored growth velocity rates associated with clinician initiation of
fortification of preterm infant human milk feedings. The following section of Chapter 5 presents
a manuscript, “Preterm Infant Growth and Human Milk Exposure in the NICU” for submission
to and possible publication in the Journal of Obstetric Gynecologic and Neonatal Nursing,
presenting the study results and synthesis of findings.
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Preterm Infant Growth and Human Milk Exposure in the NICU
Abstract
Objectives: Examine how feeding practices impact growth in infants less than 1500 gm from
birth until reaching full enteral feedings. Identify growth velocity rates associated with clinician
initiation of fortification of preterm infant human milk feedings.
Design: Retrospective descriptive study.
Setting: Level 3 neonatal intensive care unit in a small urban community in Southeast
Wisconsin.
Participants: A convenience sample of 82 very low birth weight preterm infants who were born
with birth weight < 1500 gm, vaginal or cesarean birth, born at study hospital or transferred to
study hospital within 12 hours of birth.
Methods: Data were collected from the participant’s electronic health records from birth until
the infant reached full enteral feedings.
Results: 82 preterm infants with a mean gestational age 29.30 weeks (SD 3.11) and mean birth
weight 1108.84 gm (SD 272.77) were included. In those infants who received fortification of
mother’s own milk and/or pasteurized donor human milk (53.7%), mean growth velocity was
3.89 gm/kg/day (SD 12.76) and mean volume of enteral intake was 132.60 mL/kg/day (SD
28.29). When reaching full feeding, mean growth velocity was 0.15 gm/kg/day (SD 11.09).
Conclusions: Initiation of human milk fortification or lactoengineering earlier in development
may have prevented or decreased extent of growth failure, as evidenced by growth velocity less
than 15 gm/kg/day when reaching full enteral feedings.
Keywords: Preterm infant growth, growth velocity, growth failure, fortification, human milk
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Background
Most health care providers strive to prescribe nutritional practices in the neonatal
intensive care unit (NICU) to achieve growth comparable to intrauterine life (Hay, 2013;
Kleinman & American Academy of Pediatrics [AAP], 2009; Puntis, 2006). The recommended
standard intrauterine growth rate is 15 gm/kg/day (Kleinman & AAP, 2009). Intrauterine growth
is accepted as the standard measurement for extrauterine growth for preterm infants because a
superior growth standard remains undefined (Fenton & Kim, 2013). As preterm infants are not a
homogenous group, a major conceptual flaw is created when using a standard growth rate to
define optimal growth (Embleton, Cleminson & Zalewski, 2017). Preterm infant growth is
multifactorial based on maternal and infant physiological, developmental, genetic, nutritional,
and environmental factors that differ in each preterm infant. As these variables differ among
preterm infants, it is apparent that an intrauterine rate of growth for one infant may be sufficient,
but a slower trajectory may be more appropriate and biologically plausible for the next infant
(Embleton et al., 2017).
Growth failure has consequences for short- and long-term infant health. Preterm infant
growth failure is associated with adverse neurodevelopmental outcomes and somatic
development, longer NICU stay, and potentially preventable morbidities (McLeod & Sherriff,
2007; Vasu & Modi, 2007; Walker, Keene, & Patel, 2014). Growth failure in preterm infants and
subsequent infant catch-up growth is related to increased risk for disease in adulthood, including
decreased insulin sensitivity, increased insulin resistance, altered adipose tissue metabolism
(Finken et al., 2006), obesity, and hypertension (Thomas et al., 2011). The risks associated with
growth failure or contrary, rapid catch-up growth has potential health implications that must be
weighed heavily when evaluating goal growth standards.
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It is unclear what combination of neonatal nutrition is most highly associated with
optimal preterm infant health, growth, and development (Rice & Valentine, 2015). Nutrition
management to produce adequate growth of preterm infants remains one of the most challenging
aspects of care. The types, amounts, and frequencies of feedings administered during initial
hospitalization have important implications for future infant growth and development of preterm
infants.
Human milk is the preferred feeding for preterm infants (Menon & Williams, 2013; Moro
et al., 2015). Supplementation of human milk is quickly and frequently instituted in NICUs with
bovine fortification and/or formula to maximize growth acceleration (Menon & Williams, 2013).
When preterm infants are born in the early third trimester, they miss the placental transfer of
nutrients that serve as stores for postnatal use (Henriksen et al., 2009). Fortification may provide
supplementation of missing nutritional stores in the preterm infant. Significant controversy
continues among health care professionals about how human milk should be fortified or
lactoengineered to support optimal growth (Menon & Williams, 2013).
The practical guidelines for nutritional care of preterm infants recommends fortification
of human milk in both extremely low birth weight (ELBW) and very low birth weight (VLBW)
infants when they reach feedings at 100 mL/kg/day (Senterre, 2014) at a concentration of 1:50
(Dutta et al., 2015). The AAP (2012) recommends that all preterm infants born < 1500 gm
should be fed fortified human milk. The European Society of Paediatric Gastroenteroly,
Hepatology, and Nutrition recommends that all preterm infants born less < 1800 gm should be
fed fortified human milk (Agostoni et al., 2010).
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Objectives
Our research objective was to examine how feeding practices impact growth in
hospitalized preterm infants < 1500 gm from birth until reaching full enteral feedings. We
planned to explore growth velocity rates associated with clinician initiation of fortification of
preterm infant human milk feedings.
Methods
Design and Setting
This study was a retrospective descriptive design, conducted between July 1, 2013 and
June 30, 2017, at a Level 3 NICU in a small urban community in Southeast Wisconsin that
serves an economically and racially/ethnically diverse community. Institutional Review Board
(IRB) approval was obtained prior to data collection from the hospital system as the IRB of
record and through an agreement with University of Wisconsin Milwaukee IRB. Expedited
review and waiver of informed consent was granted because there was minimal risk to infants
participating in the retrospective chart review.
Participants
The participants consisted of a convenience sample of VLBW preterm infants. Inclusion
criteria included infants born < 1500 gm by vaginal or cesarean birth at study hospital or
transferred to study hospital within 12 hours of birth. The exclusion criteria were as follows:
infants who died or were transferred prior to reaching full enteral feedings or infants born with
visible structural congenital anomalies due to their potential for special nutritional needs and
additional health concerns. Visible congenital anomalies were identified according to the
International Classification of Diseases found in the problem list of the infant’s chart.
Participants included 143 preterm infants with birth weights < 1500 gm admitted to the study
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hospital by birth or transferred within 12 hours after birth. Three infants were excluded for
congenital anomalies, 36 infants died, and 22 infants were transferred to a different hospital
before reaching full enteral feeding and were excluded from the study. The data from the
remaining 82 infants were analyzed.
Measures
Participant characteristics. We collected characteristics including sex, single or multiple
gestation, ethnicity, gestational age, length, weight, and head circumference at time of birth.
Type and amount of nutritional intake was recorded from each feeding from birth until the infant
reached full enteral feedings.
Growth velocity. Growth velocity was a measure used to summarize infant weight gain
over a specific time interval (Patel, Engstrom, Meier, Jegier, & Kimura, 2009). Growth velocity
(grams/kilogram/day) was measured using an exponential model (EM). The EM is validated for
use in all VLBW infants to examine growth (Patel et al., 2009). The EM is growth velocity =
[1000 × ln(Wn/W1)]/(Dn − D1), where W = weight in grams, D = day, 1 beginning time interval
and n = end of time interval in days (Patel, Engstrom, Meier, & Kimura, 2005). Growth velocity
was calculated over multiple time intervals: birth to time of fortification initiation, regain to birth
weight to time of fortification initiation, birth to full enteral feedings, and regain to birth weight
to full enteral feedings. Weight measurements used to calculate growth velocity were abstracted
as recorded in the electronic health record (EHR). According to the NICU policy at the
institution of study, weight should be measured on day of life one and thereafter every 3 days
until discharge from the NICU.
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Time to full enteral feeding. Time to full feeding was measured in number of days from
day of life one (birth) to 72 hours after the last intake of total parental nutrition (TPN) or parental
fluids. Each day of life is measured in calendar day hours from 0000 to 2400.
Time to fortification. Time to fortification was measured in number of days from day of
life one (birth) to day of life that human milk fortification was initiated.
Volume of enteral intake at time of fortification. Volume of enteral intake was measured
as ml/kg/day on the day fortification was initiated.
Procedures
Data were abstracted from the EHR from the sample population based on inclusion and
exclusion criteria. Data collection forms were created for the purpose of this study to abstract
participant characteristics and clinical measures. Data collection was conducted for each subject
until full enteral feedings were reached. Data were stored in an electronic format on a passwordprotected computer. To examine the data for accuracy, the primary investigator performed
double data entry on a random sample of 10 cases to check for degree of accuracy compared to
original data, and there was 100% agreement.
Statistical Analyses
All analyses were performed using SPSS® statistics 23. Participant characteristics and
clinical variables were analyzed for frequencies, frequency distributions, percentages, mean,
median, and standard deviation. The descriptive statistics of these variables were examined for
skewness, kurtosis, normality, and missing data. The descriptive statistics were used to describe
the characteristics of the sample and address all research questions.
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Results
Sample Characteristics
Eighty-two preterm infants with a mean gestational age of 29.30 weeks (SD 3.11) and
mean birth weight of 1108.84 gm (SD 272.77) were included in analyses. Mixed mother’s own
milk (MOM), pasteurized human donor milk (PDHM), fortified MOM, and fortified PDHM
composed 92.5% (SD 21.9) of the mean individual participant’s diet. The primary intake was
MOM 53.69% (SD 35.75). Mean day of life at first enteral feeding was 2.07 days. Participant
characteristics are described in Table 1.
(Table 1)
Seventy-four of 82 (90.24%) infants experienced a growth velocity less than 15
gm/kg/day at full feedings when calculated from birth weight to full feedings. Forty-eight of 82
(58.54%) infants regained birth weight prior to reaching full feedings. Birth weight was regained
at a mean of 10.12 (SD 3.55) days. Among this subgroup, 22 of 48 (45.8%) infants experienced
growth velocity less than 15 gm/kg/day after regaining birth weight to full feedings. Of the
infants studied, 44 (53.7%) received fortification of human milk and experienced a mean growth
velocity of 3.89 gm/kg/day (SD 12.76) at the time of fortification initiation. Human milk
fortification did not produce growth to maintain or exceed recommended growth velocity of 15
gm/kg/day from the time of fortification to full feedings. Among the subgroup of infants who
received fortified human milk, their mean growth velocity was 0.15 gm/kg/day (SD 11.09) at the
time they reached full feeding (Figure 1). Participant growth velocity is described in Table 2.
(Figure 1)
(Table 2)
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Forty-four (53.7%) infants received fortified human milk prior to reaching full feedings.
Human milk fortification was initiated at a mean of 14.0 (SD 5.8) days. Mean volume of human
milk intake at the time of fortification initiation was 132.61 mL/kg/day (SD 28.3; see Figure 2).
(Figure 2)
Discussion
Among the 82 preterm infants in our sample, mean growth velocity was 1.71 gm/kg/day
from birth to time of full enteral feeding. Of the 82 participants, only eight participants (9.76%)
experienced a growth velocity greater than 15 gm/kg/day. The reported frequency for those
infants who experienced growth failure, growth velocity rates less than 15 gm/kg/day (Greer &
Olsen, 2013; Griffen, 2017), were consistent with those reported in the literature. Dusick et al.
(2003) reported approximately 90% of VLBW infants are classified as having experienced
growth failure by 36 weeks corrected gestational age. Malnutrition and subsequent growth
failure in preterm infants that occurs during the postnatal period can impact both the function and
structure of the brain (Uauy & Mena, 2001). Impeded brain growth can result in irreversible
neurodevelopmental deficits, including abnormal motor and cognitive function (Butler, Szekely,
& Grow, 2013; Embleton & Tinnion, 2009; McLeod & Sherriff, 2007; Walker et al., 2014). The
severe growth failure that occurred in this sample of preterm infants is likely multifactorial.
Some of the factors that may have contributed to the severe growth failure include the delay to
initiate enteral feedings, delay to initiate fortification, feeding protocol at the hospital of study,
and appropriateness of the current growth recommendations.
In this study, enteral feedings were initiated at mean 2.07 days of life. Recommended
initiation of enteral nutrition in ELBW and VLBW infants is between six and 48 hours of life
(Senterre, 2014), preferably within 24 hours of life (Dutta et al., 2015; Embleton et al., 2017).
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Initiation of enteral nutrition is important to prevent gastrointestinal (GI) mucosal dysfunction
and atrophy by priming the gut and promoting maturation of the GI system (Neu, 2007). Early
introduction of enteral nutrition compared to fasting in VLBW infants is associated with
decreased time to reach full enteral feeds, increased weight gain, increased head growth, and
decreased time to discharge (Flidel-Rimon et al., 2004; Morgan, Young, & McGuire, 2013).
Commonly cited reasons for withholding enteral nutrition include gastrointestinal immaturity,
fear of necrotizing enterocolitis, perinatal asphyxia, lactic acidosis, patent ductus arteriosus
requiring indomethacin therapy, postnatal hemodynamic instability, or presence of an umbilical
arterial catheter (Hans, Pylipow, Long, Thureen, & Georgieff, 2009; Klingenberg, Embleton,
Jacobs, O’Connell, & Kuschel, 2011). Intestinal obstruction or ileus are the only absolute
contraindications to feeding (Dutta et al., 2015). It is unknown in this sample why initiation of
enteral feedings was delayed.
Mean volume of human milk intake at the time of fortification initiation was 132.61
mL/kg/day (SD 28.3). Fortification initiation was delayed and not started at the suggested
initiation when the infant reaches intake of 100 mL/kg/day (Dutta et al., 2015). Delay to initiate
fortification, specifically in the donor human milk group, may have contributed to growth failure.
There was no standardized protocol for fortification initiation and advancement used in
this study. Standard fortification, adding a fixed dose fortifier to human milk, was utilized and
may have provided insufficient protein, calories, or fat (Arslanoglu, Moro & Zeigler, 2006;
Krcho, Vojtova, & Benesova, 2015). Despite fortification, the participants in this study
experienced growth failure. In the subgroup of infants who experienced fortification (n = 44), the
growth velocity was 3.89 gm/kg/day at the time of fortification initiation, and the growth
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velocity was 0.15 gm/kg/day at time of full feeding, suggesting they were barely growing.
Similar findings are present in the literature.
Henriksen et al. (2009) examined growth in 127 VLBW infants who received initiation of
enteral feedings on the first or second day of life and experienced fortification initiation of MOM
or PDHM when achieving enteral intake of 120 ml/kg. Of the infants studied, 58% demonstrated
growth failure at discharge (Henriksen et al, 2009). The current consensus statement on human
milk feeding in preterm infants recommends that fortification begins with standard fortification,
5 gm/100 ml of human milk providing 0.8 g of protein, with advancement to individualized
fortification if growth is inappropriate (Moro et al., 2015). Arslanoglu et al. (2006) found
individualized fortification with bovine fortifier and aggressive protein supplementation based on
infant blood urea nitrogen levels safe and effective up to 1.8 gm of protein, with significantly
greater weight, head circumference, and growth velocity. Adjustable fortification with bovine
fortifier had an average growth velocity of 17.5 ± 3.2 gm/kg/day compared to standard
fortification with bovine fortifier 14.4 ± 2.7 gm/kg/day (Arslanoglu et al., 2006).
At our study site, the feeding protocol included scheduled interval feedings every four
hours. While we did not analyze data on the frequency of feeds for this sample, it should be
acknowledged that the feeding protocol at the study site did not follow recommended practices.
In infants weighing less than 1250 gm, feedings should be administered at three hour intervals
(Dutta et al., 2015). It may even be advantageous to feed preterm infants weighing greater than
1250 gm at two-hour intervals (DeMauro, Abbasi & Lorch, 2011; Premji & Chessell, 2011) or
semi-demand (Watson & McGuire, 2016). DeMauro et al. (2011) reported that VLBW infants
with mean birth weight of 1200 gm who were fed at two-hour intervals reached full feedings
faster and experienced decreased incidences of feeding intolerance and TPN for shorter lengths
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of time compared to those infants fed at three hour intervals. Watson and McGuire (2016)
reported that semi-demand feedings were correlated with earlier achievement of full oral
feedings, increased nutrient intake and growth rates, and earlier discharge from the NICU by two
to four days. In addition, by decreasing the time between feedings, we are decreasing the stretch
of the stomach and are meeting the normal GI physiology of stomach volume capacity and
gastric emptying of breastmilk (Bergman, 2013). Feeding preterm infants with larger volumes at
longer intervals has been associated with increased risk for stress, reflux, and hypoglycemia
(Bergman, 2013).
Lastly, the recommended growth standard, 15 gm/kg/day, for one preterm may be
sufficient, but a slower trajectory may be more appropriate for a different infant (Embleton et al.,
2017). It is possible that if a preterm infant’s growth appears stable and is moving appropriately
across percentiles and there is no underlying contributing pathology, then quite possibly, this
may be optimal (Embleton et al., 2017). Further research studies are needed to address if NICU
growth velocity goals should be redefined and how feedings and growth should be managed. The
failure of many infants to achieve the desired growth velocity may indicate inadequacy of the
current standard.
Limitations
There are two key limitations within this study, including the sampling plan and research
design. Nonprobability convenience sampling was used. Generalizability of the findings are
limited by the small sample size and use of a single site with a feeding protocol that is not
aligned with current practice standards. As a retrospective study, it is not possible to control
missing/unrecorded data, errors in documentation, verification of documentation, and reliability
of growth measurements obtained and recorded by nursing staff. It is important to consider the
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reliability of the growth measures, as they are a direct indicator of the quality of data. There also
may be confounding variables that could not be controlled, including perinatal risk factors,
postnatal co-morbidities, types/timing of TPN compositions, types and timing of fortification,
nutrient composition of maternal/donor milk, and the infant’s response to the environment inside
and outside of the isolette. These confounding variables can affect the proposed outcome
measures. In the future, I would suggest replication of the study utilizing a prospective approach
with standardized approach to feeding based on the best evidence. Using an alternative
prospective interventional study design would allow the research team to manage the multiple
measurement issues described and allow for greater control over possible confounding variables.
Training of all NICU staff who perform routine anthropometric measurements should be
conducted to monitor and verify the reliability of these measures, both for research and for
clinical practice.
Conclusion
Our research findings are consistent with the existing literature that the failure of many
infants to achieve the desired growth velocity may indicate inadequacy of the current feeding
standards or feeding recommendations. However, in this study sample, suboptimal nutrition
management likely contributed to poor quality of growth. Growth failure occurred in this study
sample, as evidenced by growth velocity less than 15 gm/kg/day when reaching full enteral
feedings. Initiation of human milk fortification or lactoengineering earlier in development may
have prevented or decreased extent of growth failure. Lactoengineering, utilizing high fat milk
cream from the human milk sample, can provide increased fat and energy content (Hair et al.,
2014). Lactoengineering may have a promising future to support an exclusive human milk diet in
preterm infants to provide energy-dense feedings without substantial increase in the total volume
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of feeds. There is a need for more high quality clinical research to optimize preterm infant
nutrition through human milk lactoengineering and fortification.
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Table 1
Participant Characteristics
Variable
Sex
Female
Male
Type of Gestation
Single gestation
Multiple gestation
Ethnicity
Caucasian
Black
Hispanic

Frequency

Percent

38
44

46.3
53.7

68
14

82.9
17.0

29
43
10

35.4
52.4
12.2

Mean
Diet
Mother’s own milk (MOM),
% of total intake
Donor human milk (PDHM),
% of total intake
MOM mixed with PDHM,
% of total intake
Fortified MOM, % of total
Intake
Fortified PDHM, % of total
Intake
MOM, PDHM, fortified
MOM, fortified PDHM, % of
total intake
Formula, % of total intake
Gestational age at birth, weeks
Birth weight, gm
Birth length, cm
Birth head circumference, cm
Age at first enteral feeding, days

SD

Minimum

Maximum

53.69

35.75

0.00

100

20.87

33.03

0.00

100

.08

.70

0.00

6.3

11.62

16.76

0.00

73.49

6.18

15.31

0.00

65.82

92.46

21.87

0.00

100.00

7.54
29.30
1108.80
36.57
25.90
2.07

21.87
3.10
272.70
3.47
2.51
.72

0.00
23.70
530.00
28.00
17.50
1.00

100.00
36.86
1499.00
43.20
30.00
5.00
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Table 2
Growth Velocity
Participants
All Participants (N = 82)
Growth velocity from
birth to full enteral
feeding (gm/kg/day)
Subgroup of infants that
reached birth weight prior
to full enteral feedings (n
= 48)
Growth velocity at
time birth weight was
regained to full enteral
feeding (gm/kg/day)
Subgroup of infants that
experienced fortification
(n=44)
Growth velocity from
birth to initiation of
fortification
(gm/kg/day)
Growth velocity from
birth to full feedings of
those infants receiving
fortification

Mean

SD

Minimum

Maximum

1.71

10.67

-23.37

26.91

15.46

6.41

1.25

32.60

3.89

12.76

-35.73

26.62

0.15

11.09

-23.37

17.72
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Figure 1. Change in growth velocity from birth to full enteral feeding.
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Intake at time of fortification
(mL/Kg/day)

Intake Volume at the Time of Fortification of Human Milk
200
180
160
140
120
100
80

Recommended
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fortification at
100 ml/kg/day
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Participants

Figure 2. Intake volumes at the time of fortification of human milk.
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Chapter VI: Implications for Nursing Practice, Research, and Policy
Chapter VI discusses implications for nursing practice, research, and policy. The section
following Chapter VI is the article, “The Political Imperative of an Exclusive Human Milk Diet”
submitted and currently under review for publication in the Journal of Human Lactation. This
manuscript describes and outlines clear recommendations for federal policy expansion of the
Affordable Care Act to mandate health insurance company provisions of appropriate coverage of
equipment for expression of mother’s milk and supply of donor human milk and/or donor human
milk-based fortifier to promote and support an exclusive human milk diet for preterm infants.
Implications for Nursing Practice
This study has many implications for nursing practice and for those involved in the care
of preterm infants, their growth and development, and the use of human milk, including
prescribers, occupational therapists, nutritionists, scientists, and patients. The startling failure of
infants to achieve the desired growth velocity of 15 gm/kg/day uncovered in this study may
indicate inadequacy of the current growth standards or feeding recommendations, which the
entire health care team is failing to address in the NICU setting.
For those nurses working in the United States, fortification of human milk in the NICU
has become a standard of care (Spatz, 2017). Brown, Embleton, Harding, and McGuire (2016)
performed a meta-analysis examining 14 trials including 1,071 infants and found low quality
evidence that fortification during NICU hospitalization increases growth rates of head
circumference (mean difference [MD] 0.08 cm/week, 95% confidence interval [CI] 0.04-0.12),
length (MD 0.12 cm/week, 95% CI 0.07- 0.17), and weight (MD 1.81 gm/kg/day, 95% CI 1.232.40). The expected growth standard in NICUs has remained 0.5 cm to 0.7 cm/week in head
circumference, 1 cm/week in length, and 15 gm/kg/day in weight because a superior growth
standard has remained undefined (Fenton & Kim, 2013; Greer & Olsen, 2013; Kleinman &
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AAP, 2009). It is evident through meta-analysis that the failure of infants to achieve the desired
growth velocity with fortification of human milk may indicate inadequacy of the current growth
standard (Brown et al., 2016; Spatz, 2017). It is unclear what optimal growth and associated
nutrition is for preterm infants. It is possible that if a preterm infant’s growth appears stable and
is moving appropriately across percentiles, and there is no underlying contributing pathology,
then quite possibly this may be optimal (Embleton et al., 2017). It is critical that attention is
focused on quality of preterm infant growth, while searching for optimal nutrition composition
and management.
What is clearly known is that preterm infants fed an exclusive human milk diet
demonstrate improved morbidity compared to formula fed infants (National Breastfeeding
Center, 2016). Despite many uncertainties in neonatal growth and nutrition, there is a strong
relationship between improved health outcomes and a protective dose response relationship with
the duration and/or exclusivity of human milk (Embleton et al., 2017). Currently, use of MOM in
the NICU is not prioritized in a manner comparable to other interventional NICU therapies
(Meier, Patel, Bigger, Rossman, & Engstrom, 2013). In addition, families and NICU staff have
inconsistent education and lactation technologies to optimize duration and exposure of MOM
(Meier et al., 2013). Development and utilization of practices and interventions to optimize use
of mother’s milk should be priority. These practices should include policies and procedures on
initiation and frequency of pumping and use of human milk and human milk technologies,
utilization of peer counselors, translation of evidence regarding human milk into actionable
practices for providers, talking points for staff to ensure information is shared consistently and
accurately, and clear messaging that supports human milk as both a source of nutrition and
medicine (Meier et al., 2013).
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Implications for Further Research
There are multiple opportunities to close the research gap regarding the use of human
milk to promote preterm infant growth. In this specific research study, the population was limited
to retrospective review, where it was not possible to control for missing/unrecorded data, errors
in documentation, and reliability of anthropometric growth measures. There are likely
confounding variables that could not be controlled, which include perinatal risk factors, postnatal
co-morbidities, types/timing of total parental nutrition compositions, types and timing of
fortification, nutrient composition of maternal/donor milk, and the infant’s response to their
environment inside and outside of the isolette. Follow-up research should include replication of
this study utilizing a prospective approach expanding measurement abstraction to include type of
fortification, type of pasteurized donor human milk, infant environment (isolette/open
crib/phototherapy/kangaroo care), respiratory support, morbidities, daily weights, weekly length
and head circumference from birth to hospital discharge with a standardized approach to feeding
based on the best evidence. A prospective approach would allow the research team to manage the
multiple measurement issues described above and allow for greater control over possible
confounding variables.
Further research studies are needed to address if NICU growth velocity goals should be
redefined. The risks associated with growth failure or contrary, rapid catch-up growth, has
potential health implications that must be weighed heavily when evaluating goal growth
standards (Kiger et al., 2016; McLeod et al., 2015; Ong et al., 2000; Sauer, 2007). While some
research suggests that catch-up growth is required for preterm infant brain development, others
report it is at the possible risk of harmful cardiovascular and metabolic outcomes later in life
(Kiger et al., 2016; McLeod et al., 2015; Ong et al., 2000; Sauer, 2007). The current literature on
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preterm infant catch-up growth and subsequent increased body fat suggests that the current
growth and nutrition recommendations are not effective or safe to achieve normalized body
composition postnatally (Kiger at al., 2016). It is possible that lower nutrient intake and slower
growth may be protective longitudinally (Embleton et al., 2017). Given the potential for slower
growth to affect important outcomes in preterm infants, examining slower growth velocity merits
further research. The relationship between fetal and neonatal growth and alteration of subsequent
metabolic and cardiac function to prevent risk for harm later in life should be examined. Weight
gain by itself may not be adequate to inform the impact and practice of nutrition on growth
(Forsum, Olhager & Tornqvist, 2016). Other indices that can inform body composition including
ponderal index and BMI, should be further investigated as a parameter of growth in future
studies as body composition is predictive of future disease risk (Wells, 2012).
For all disciplines, including nurses, physicians, registered dieticians, and physical and/or
occupational therapists, to make clinical decisions regarding use of human milk for preterm
infants, they must understand how preterm infant growth is multifactorial based on dynamic
interactions between maternal, fetal, and infant physiological, developmental, genetic,
nutritional, and environmental factors that can greatly differ between each infant. There are
multiple reasons for prenatal and postnatal preterm infant growth failure. Commonly cited
reasons for prenatal growth failure include placental insufficiency, fetal programming, maternal
inflammation, or infection (Goldenberg, Culhane, Iams, & Romero, 2008). Commonly cited
reasons for postnatal growth failure include inadequate nutrition, genetic acquired diseases,
physiologic immature organ states, liver disease, endocrine abnormalities, surgery, infection,
cold stress, and medications (Bartholomew et al., 2013; Hay, 2013; Hay, Brown, & Denne, 2014;
Vinall et al., 2012). The precise mechanism within the maternal and infant systems that influence
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individual preterm infant growth failure cannot be established in most cases and is likely a
combination of multiple interactions (Goldenberg et al., 2008). Serious commitment to define
modifiable risk factors within maternal and infant systems to predict preterm infant growth
failure is warranted. The Physiological Growth Model was supported in the literature and the
study findings, however, it is a basic foundation that requires further refinement. Other possible
prenatal growth factors for preterm infant growth may include mother’s weight status and
nutritional status. The complexity of growth variables among maternal and infant system has
been largely unexplored and is a vast area for future research.
Lastly, there is a need for more high-quality clinical research to optimize preterm infant
nutrition through human milk lactoengineering. Lactoengineering, utilizing high fat milk cream
from the human milk sample, can provide increased fat and energy content (Hair et al., 2014,
Ogechi et al., 2007, Slusher et al., 2003). Lactoengineering may have a promising future to
provide energy dense feedings without substantial increase in the total volume of feeds. Given
the potential of lactoengineering to support an exclusive human milk diet that is genetically
engineered for each individual infant and subsequent effects on important outcomes in preterm
infant growth and health, this intervention merits further research. An exclusive human milk diet
is associated with decreased risk of NEC, respiratory infection, sepsis, and overall survival
(Palmer, 2015). Interventional studies comparing different preparations of high fat milk cream,
powered to detect important effects on growth rates and adverse events, including NEC, in
preterm infant hospitalization and beyond, should be designed. The protocols used for
lactoengineering and creamatocrit measurements should be published. In addition, investigators
should examine the effects of lactoengineering compared to use of human milk based fortifier to
determine if it provides cost effective advantages during preterm infant hospitalization.
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The Political Imperative of an Exclusive Human Milk Diet in Preterm Infants
Abstract
The United States is well overdue for a federal mandate of insurance companies to cover a
different type of medicine for preterm infants—human milk. For nearly all infants, human milk
is the superior and preferred food. Human milk is not only a fundamental basic need, but it can
be a lifesaving food and medicine for medically fragile preterm infants. Anti-inflammatory and
anti-infective properties specific to human milk, which are not found in formula, can help
prevent serious or fatal health conditions in preterm infants. However, preterm infants who
benefit greatest from consuming human milk may have the most difficulty receiving it. The
associated costs in providing human milk can lead to inequitable access to an exclusive human
milk diet for many preterm infants and contribute to breastfeeding disparities. The purpose of
this manuscript is to describe and outline clear recommendations for federal policy expansion of
the Affordable Care Act to mandate health insurance company provisions of appropriate
coverage of equipment for expression of mother’s milk and supply of donor human milk and/or
donor human milk-based fortifier to promote and support an exclusive human milk diet for
preterm infants.
Background
The United States is well overdue for federal mandate of insurance companies to cover a
different type of medicine for preterm infants—human milk. For nearly all infants, human milk
is the superior and preferred food. Human milk has immunologic benefits that offer health
protection and disease reduction across the lifetime for infants and mothers (U.S. Department of
Health and Human Services, 2011). A minimum of $13 billion dollars in medical expenses and
911 infant deaths per year could be saved if 90% of families in the United States breastfed
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exclusively for six months, with continued breastfeeding to one year old (Bartick & Reinhold,
2010).
Worldwide, approximately one million children die annually due to complications of
preterm birth (Liu et al., 2016). Preterm birth is defined as those infants born before 37
completed weeks gestation. Globally, preterm infant birth is a significant problem, with
increasing preterm infant birth rates in almost all countries that report preterm infant birth rates
(World Health Organization [WHO], 2018). In 2017, the preterm infant birth rate rose for the
third year in a row to 9.93% in the United States (Hamilton, Martin, Osterman, Driscoll &
Rossen, 2018). The United States is ranked sixth of 10 countries that account for the highest
number of preterm births annually (Blencowe et al., 2012).
Human milk can be a lifesaving food and medicine for medically fragile preterm infants.
Anti-inflammatory and anti-infective properties specific to human milk, which are not found in
formula, can help prevent serious or fatal health conditions in preterm infants. However, preterm
infants who benefit greatest from consuming human milk may have the most difficulty receiving
human milk. Barriers to preterm infants receiving human milk may include a maternal disease/
surgery/death, maternal use of drugs or certain medications, inadequate or no milk available, and
associated costs. The associated costs in providing human milk can lead to inequitable access to
an exclusive human milk (EHM) diet for many preterm infants.
Providing human milk for preterm infant nutrition is a matter of women and infant health
that should be accessible and affordable for all who desire to utilize it. A federal mandate of
health insurance coverage to provide appropriate equipment for expression of mother’s milk and
supply donor human milk and donor human milk-based fortifier is a fundamental basic need for
preterm infants. The purpose of this manuscript is to describe and outline clear recommendations
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for federal policy expansion of the Patient Protection and Affordable Care Act (ACA, 2010) to
mandate health insurance company provisions of appropriate coverage of equipment for
expression of mother’s milk and supply of donor human milk and/or donor human milk-based
fortifier to promote and support an EHM diet for preterm infants. As the ACA currently stands,
the specific needs for human milk and preterm infants is not addressed.
Despite historic health reform in the ACA (2010) to include provisions to support
breastfeeding, the current state of the ACA represents a disconnected patchwork rather than a
unified direction towards eliminating breastfeeding disparities for preterm infants (Hawkins,
Dow-Fleisner & Noble, 2015). Disparity exists when there is a difference in access and
opportunity to healthcare that results in differences in underlying health (Jones, Jones, Perry,
Barclay & Jones, 2009). As it currently stands, the ACA provides health insurers the power to
decide, act, and control supply of human milk for preterm infants that can subsequently result in
decreased spending on breastfeeding support. A recent example includes Anthem Blue Cross
Blue Shield’s decision, effective April 1, 2018, to cut coverage of breast pumps by 45%, from
$169 to $95 (United States Breastfeeding Committee, 2018). Anthem Blue Cross Blue Shield
provides insurance coverage of over 40 million Medicaid enrollees, a specific group that includes
low income families. This decision to decrease reimbursement to improve profits was a cut in
breastfeeding support that further fuels breastfeeding disparity (United States Breastfeeding
Committee, 2018).
Limitations of the Affordable Care Act and Breastfeeding Preterm Infants
A major provision in the ACA (2010), Section 2713 Women’s Preventative Service,
requires health plans to cover costs associated with providing human milk to infants. This
provision requires health plans to cover breastfeeding supplies, including breast pump rental or
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purchase and breastfeeding counseling/educational services (ACA, 2010). Within this provision,
there lacks clear language or guidelines as to the type of equipment that should be covered, and
as a result, there are extreme inconsistencies in equipment coverage and disrupted continuity of
breastfeeding services, which can result in failure to supply human milk for those in need
(National Breastfeeding Center, 2016).
Mothers of preterm infants commonly require a hospital-grade electric breast pump to
initiate and support milk supply. Mothers of preterm infants should initiate pumping with a
hospital-grade breast pump within six hours postpartum, with minimum of eight pumping
sessions daily, to protect future milk production potential (Stanford Medicine, 2017). Under
current ACA provisions, approximately 23% of insurance companies do not cover this type of
pump (Medela, 2013). Some insurers only cover a manual hand pump, which is not adequate to
establish or maintain milk supply when a mother is separated from her infant or unable to feed
directly from the breast, as is many times the case for preterm infants (National Breastfeeding
Center, 2016). The remaining 77% of insurance companies that provide insurance coverage of
electric-grade pumps may require preauthorization, which can take days or even weeks after the
birth of the infant to obtain (Medela, 2013; National Breastfeeding Center, 2016).
Lastly, for those mothers of preterm infants who are unable to provide mother’s milk,
donor human milk is a great alternative that offers similar health protections to mother’s milk
(Vongbhavit & Underwood, 2016). Carroll and Herrmann (2013) reported that 72% of mothers
of very preterm infants in the NICU were unable to provide all mother’s milk needed for an
EHM diet. Hospitals that use banked donor milk generally have minimal budgets allocated for
purchase of donor milk (National Breastfeeding Center, 2016). Donor human milk costs, on
average, $4.50 per ounce; however, for every $1.00 spent on donor milk, there is a potential
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saving up to $11.00 in medical costs of the preterm infant (Huertas, 2015). The ACA does not
address coverage of donor milk.
Mother’s milk and donor human milk may not always meet the high nutrient needs of
preterm infants without fortification (Schanler, Lau, Hurst, & Smith, 2005). Fortification of
human milk provides increased protein and is correlated with exceeding expected growth
velocity and improving weight gain and linear growth (Reali et al., 2015; Rochow et al., 2013).
The American Academy of Pediatrics (2012) recommends that all human milk should be
fortified with protein, minerals, and vitamins in preterm infants weighing less than 1,500 grams
at birth.
The two primary types of fortification include donor human milk-based fortifier or a
bovine milk-based fortifier. Bovine fortifier is the most commonly used fortifier in NICUs due to
immediate upfront cost. However, use of a bovine fortifier in human milk exposes the infant to
non-human milk protein and is associated with possible serious health issues, including increased
risk of necrotizing enterocolitis (NEC), respiratory infection, sepsis, and overall reduced survival
(Underwood, 2013).
The potential long-term cost savings by adhering to an EHM diet and avoiding bovine
fortifier is profound among extremely preterm infants in the NICU. In avoidance of NEC alone,
Ganapathy, Hay, and Kim (2012) reported a lower expected NICU length of stay of 3.9 NICU
days and net direct average savings of $8,167.17 per extremely premature infant (p < 0.0001)
fed EHM diet compared to those infants fed a bovine fortified diet. Since there is no federal
regulation requiring insurance coverage of donor human milk-based fortifier, it remains
significantly underutilized.
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Recommendations
Development of Policy Expansion
No infant should be exposed to suboptimal nutrition. Surviving preterm infancy should
not be constrained by cost or maternal supply limitations. To specifically address support and
delivery of an EHM diet for preterm infants, clear policy recommendations for provision
expansion of section 2713 Women’s Preventative Services in the ACA (2010) or other future
replacement policies are proposed. The three primary areas for provision expansion are coverage
of breastfeeding pumps and supplies, coverage of donor milk, and coverage of donor human
milk-based fortification. These areas of provision expansion are economically driven and provide
substantiated health benefits for mothers and infants. These recommendations are supported by
policy statements from the WHO (2018) recommending standard nutrition practices in NICUs to
promote mother’s milk first, followed by donor human milk when mother’s milk is unavailable
(Krolak-Olejnik & Czosnykowska-Lukacka, 2017). These areas for provision would require
health plan coverage of services and supplies that align with recommended best nutrition
practices for preterm infants.
Breastfeeding Pumps and Supplies
Breast pump coverage is to include a dual electric-grade breast pump with a breast pump
kit (tubing, valves, flanges, collection bottles, and other parts as specified by the manufacturer)
for use of mothers of preterm infants for the first year of the child’s life. Up to 16 human milk
storage bags per day would be covered to allow for expression and storage of human milk every
three to four hours. An electric-grade breast pump should be made available within 24 hours of
notification of need (National Breastfeeding Center, 2016), with no cost sharing to the member.
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Donor Human Milk
In cases when mother’s milk is not available, banked donor human milk is the first choice
for preterm infants. Pasteurized donor milk, provided from an approved Human Milk Banking
Association of North America milk bank, will be a covered benefit for preterm infants (National
Breastfeeding Center, 2016). Prescription from a licensed provider that identifies the medical
diagnosis and necessity and 3-month renewal of the prescription will be required (National
Breastfeeding Center, 2016). The covered benefit will include infants from birth to 12 months of
age, when decided by a medical provider that it is medically necessary (National Breastfeeding
Center, 2016), with no cost sharing to the member.
Donor Human Milk-Based Fortifier
In cases when fortification of mother’s milk or donor human milk is required, as
identified by a medical provider, human milk-based fortifier will be a covered benefit.
Prescription from a licensed provider that identifies the medical diagnosis and necessity will be
required, along with a 3-month renewal of the prescription. The covered benefit will include
infants from birth to 12 months of age, when decided by a medical provider that it is medically
necessary, with no cost sharing to the member.
Conclusion
Mothers and preterm infants need uncompromised and high quality breastfeeding
support. Providing an EHM diet to vulnerable preterm infants can make a lifesaving difference
and provide large economic healthcare cost savings. As it currently stands in the ACA (2010),
the lack of coverage of appropriate breast pumps and supplies, donor human milk, and human
milk-derived fortifier leads to inequitable access for an EHM diet for preterm infants. The
outlined federal policy expansion would provide landmark legislation designed to improve the
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quality, delivery, and efficiency of providing human milk for preterm infant feeding in the
United States. These recommended approaches to policy change are greatly needed to address
breastfeeding as a national priority (Hawkins et al., 2015). It is imperative that in discussion of
repeal and replacement of the ACA, consideration for breastfeeding expansion address preterm
infant nutrition. It is now time to call on policymakers, lobbyists, healthcare providers, and
stakeholders to advocate for these provisions and make legislative efforts to ensure equitable
comprehensive access of human milk for all preterm infants.
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